Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023430	s-kisshie	— (—)	3832	3958	100.00%	Distribution not available
3023430	s-kisshie	kU/l (u/ml)	3621	3900	1.82%
3023430	kissa	— (—)	609	639	100.00%	Distribution not available
3023430	kissa	kU/l (u/ml)	146	150	0.00%
3023430	s-kisshie	kU/l______ (u/ml)	71	71	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Atopic dermatitis

1717

4946

2.85

319.07

1.1

8.00

4.11

u/ml

9.45

1005

2064

Asthma-related infections

1546

3990

3.90

307.65

1.1

1.0

5.91

4.47

u/ml

1.87

958

1586

Pollen allergy

1374

2085

7.39

307.65

1.1

6.81

5.25

u/ml

1.42

895

893

Chronic sinusitis

994

2513

4.08

307.65

1.1

1.0

2.96

4.54

u/ml

2.26

505

949

Asthma and allergy

847

986

9.45

307.65

1.1

1.0

8.92

5.60

u/ml

2.52

623

363

1345

3361

4.13

307.65

1.1

1.0

6.26

4.77

u/ml

1.66

838

1354

Asthma/COPD (KELA code 203)

2516

4732

3.66

307.65

1.1

1.0

6.68

3.99

u/ml

6.74

1465

1822

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1610

4916

3.25

307.65

1.1

4.49

5.16

u/ml

0.78

962

2037

Asthma (mode)

2294

2375

5.26

307.65

1.1

1.0

5.62

4.55

u/ml

1.16

1380

811

Asthma, hospital admissions , main diagnosis only

2430

5513

3.97

307.65

1.1

1.0

6.12

4.39

u/ml

3.35

1484

2202

Asthma, unspecified (mode), excluding more controls

1148

2118

3.98

307.65

1.1

1.0

4.03

4.50

u/ml

0.34

591

719

Conjunctivitis

1939

5721

2.80

307.65

1.1

4.88

5.52

u/ml

0.78

1128

2437

Asthma, excluding more controls

2260

2345

5.14

307.65

1.1

1.0

5.71

4.63

u/ml

1.16

1355

797

Asthma and allergy, excluding more controls

847

1010

9.23

307.65

1.1

1.0

8.92

5.36

u/ml

2.90

623

373

Allergic conjunctivitis

1660

5218

3.17

307.65

1.1

4.58

5.37

u/ml

1.01

996

2174

Vasomotor and allergic rhinitis

1843

2946

6.58

307.65

1.1

1.0

6.87

5.30

u/ml

1.82

1156

1162

Asthma, unspecified (mode)

1154

2135

4.00

307.65

1.1

1.0

4.01

4.44

u/ml

0.32

594

727

Asthma, including avohilmo

3433

4337

4.51

307.65

1.1

1.0

6.04

3.73

u/ml

6.79

1908

1672

Asthma, hospital admission 2, infections

1546

3990

3.90

307.65

1.1

1.0

5.91

4.47

u/ml

1.87

958

1586

Allergic rhinitis

1747

2961

6.37

307.65

1.1

6.92

5.13

u/ml

2.19

1125

1201

Asthma (only as main-diagnosis), excluding more controls

2248

2345

5.52

307.65

1.1

1.0

5.59

4.63

u/ml

0.99

1348

797

Chronic lower respiratory diseases

3126

4747

3.57

307.65

1.1

1.0

6.16

4.05

u/ml

5.33

1784

1828

Allergic asthma (mode)

1136

1567

7.61

307.65

1.1

1.0

7.86

5.01

u/ml

3.08

822

562

Asthma (diagnoses ohter than nonallergic)

2504

5380

3.89

307.65

1.1

1.0

6.24

4.34

u/ml

4.02

1546

2122

Asthma

2280

2366

5.15

307.65

1.1

1.0

5.67

4.57

u/ml

1.20

1368

807

Allergic asthma (mode), excluding more controls

1135

1573

7.58

307.65

1.1

1.0

7.87

5.03

u/ml

3.05

821

562

Chronic rhinitis, nasopharyngitis and pharyngitis

835

1948

4.45

307.65

1.1

1.0

3.51

4.92

u/ml

1.44

446

758

Disorders of conjunctiva

1979

5858

2.68

307.65

1.1

4.86

5.48

u/ml

0.75

1145

2494

Asthma (only as main-diagnosis)

2259

2366

5.55

307.65

1.1

1.0

5.57

4.57

u/ml

1.04

1355

807

Other diseases of upper respiratory tract

1927

3752

2.72

294.85

1.1

1.0

5.53

4.96

u/ml

0.45

1026

1472

Obesity related asthma

773

1896

4.21

281.76

1.1

1.0

5.39

3.60

u/ml

1.36

429

674

Desensitization to allergens

422

660

7.51

265.75

1.1

6.68

5.59

u/ml

0.45

298

311

Atopic dermatitis, strict definition with reimbursement

1052

3265

3.23

252.08

1.1

9.61

4.70

u/ml

8.37

716

1415

Nasal polyp

424

696

6.33

247.07

1.2

1.0

3.52

2.84

u/ml

0.39

267

263

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

951

2901

3.23

233.51

1.1

1.0

3.42

4.34

u/ml

1.00

482

1116

Suggestive for eosinophilic asthma

278

314

9.44

226.68

1.2

1.0

3.68

3.40

u/ml

0.09

196

118

Dermatitis and eczema

2069

5573

2.23

218.16

1.1

6.85

3.85

u/ml

7.27

1127

2345

Undetermined asthma

322

524

6.39

189.23

1.1

1.0

3.28

4.46

u/ml

0.47

177

Undetermined asthma, excluding more controls

322

529

6.33

187.44

1.1

1.0

3.28

4.42

u/ml

0.45

177

179

Other pulmonary diagnosis

1268

2405

2.68

187.20

1.1

1.0

4.66

4.53

u/ml

0.07

632

829

COPD differential diagnosis

1251

2376

2.68

184.24

1.1

1.0

4.64

4.65

u/ml

0.00

627

812

ILD differential diagnosis

1249

2375

2.67

183.51

1.1

1.0

4.65

4.55

u/ml

0.05

626

811

Atopic dermatitis, strict definition

979

3567

2.79

182.02

1.1

10.43

5.11

u/ml

8.75

667

1578

Excluding asthma or asthma-COPD overlap

1253

2405

2.65

180.91

1.1

1.0

4.68

4.53

u/ml

0.09

624

829

Oral corticosteroids

1887

5231

2.14

180.67

1.1

4.64

4.83

u/ml

0.17

1030

2179

Asthma-related pneumonia or sepsis

601

1680

3.64

180.28

1.1

1.0

4.64

4.90

u/ml

0.13

387

651

Asthma, hospital admissions 3, pneumonia

601

1680

3.64

180.28

1.1

1.0

4.64

4.90

u/ml

0.13

387

651

Asthma-related pneumonia

598

1674

3.64

179.01

1.1

1.0

4.65

4.90

u/ml

0.12

386

647

Cough

817

2576

3.03

178.22

1.1

4.88

5.47

u/ml

0.28

421

1135

ILD medications: prednisolone, methylprednisolone, prednisone

1925

5268

2.06

163.77

1.1

4.88

5.11

u/ml

0.20

1039

2243

Childhood asthma (age<16)

522

1069

4.01

162.80

1.1

1.0

10.21

5.86

u/ml

3.01

374

398

Childhood asthma (age<16), excluding more controls

521

1071

3.99

161.61

1.1

1.0

10.23

5.87

u/ml

3.01

373

399

Biological medicines for asthma

162

168

11.56

143.98

1.3

1.1

6.15

6.44

u/ml

0.05

120

FESS (DNB20)

357

833

4.51

140.29

1.2

1.1

2.52

4.04

u/ml

1.27

198

354

Diseases of the respiratory system

940

1787

2.67

138.39

1.1

1.0

4.93

4.37

u/ml

0.33

447

614

Ethmoidectomy

361

862

4.40

137.61

1.2

1.1

2.49

3.95

u/ml

1.24

200

368

Deviated nasal septum

487

1429

3.47

136.30

1.1

1.0

3.96

3.66

u/ml

0.14

249

532

Abnormalities of breathing

1647

4736

2.02

133.71

1.1

5.64

5.22

u/ml

0.26

804

2119

ILD medications

1922

5541

1.89

128.32

1.1

4.99

5.36

u/ml

0.36

1025

2416

Inflammatory bowel disease treatment related agents

1919

5726

1.88

126.85

1.1

4.79

5.12

u/ml

0.33

1034

2467

Conjunctivitis (acute, non atopic), including avohilmo

1568

4841

1.98

122.86

1.1

4.77

5.41

u/ml

0.64

769

2032

First line medication for Crohn's disease

1828

5506

1.80

105.78

1.1

5.21

5.26

u/ml

0.03

967

2402

Symptoms and signs involving the circulatory and respiratory systems

1719

4758

1.83

102.19

1.1

5.61

5.22

u/ml

0.24

840

2127

Chronic diseases of tonsils and adenoids

1175

3687

2.03

100.59

1.1

1.0

5.36

5.05

u/ml

0.16

563

1441

Adverse effects, not elsewhere classified

509

1863

2.83

98.55

1.1

6.28

5.83

u/ml

0.19

325

873

Childhood allergy (age < 16)

589

2000

2.54

87.05

1.1

12.30

5.88

u/ml

6.40

416

947

Non-allergic asthma (mode)

283

792

3.61

84.23

1.1

1.0

3.68

5.19

u/ml

0.51

119

289

Insomnia

1478

5889

1.77

84.18

1.1

4.90

4.83

u/ml

0.04

666

2691

Non-allergic asthma (mode), excluding more controls

283

795

3.60

83.76

1.1

1.0

3.68

5.23

u/ml

0.52

119

291

Sleep disorders

1466

5844

1.75

80.29

1.1

4.81

4.80

u/ml

0.00

664

2684

Urticaria

650

2931

2.27

79.94

1.1

5.32

5.87

u/ml

0.27

368

1340

Acute sinusitis

982

4656

1.95

79.72

1.1

4.31

4.74

u/ml

0.33

479

2044

Urticaria and erythema

719

3417

2.15

77.28

1.1

5.57

5.69

u/ml

0.05

403

1562

Acute upper respiratory infections

1508

5303

1.72

76.29

1.1

5.11

4.91

u/ml

0.12

729

2343

Acute upper respiratory infections of multiple and unspecified sites

1255

5163

1.79

76.11

1.1

5.62

4.97

u/ml

0.44

620

2274

Behavioural syndromes associated with physiological disturbances and physical factors

1485

5976

1.70

73.49

1.1

4.96

u/ml

0.00

674

2767

Dermatitis due to ingested food

200

500

4.22

68.33

1.2

1.1

11.94

9.03

u/ml

0.75

151

262

Other and unspecified effects of external causes

594

2769

2.19

67.41

1.1

6.15

5.81

u/ml

0.16

360

1290

Dyspnoea

1245

5236

1.73

67.21

1.1

4.73

4.66

u/ml

0.03

613

2318

Sleep apnoea, including avohilmo

1353

4834

1.71

66.98

1.1

3.30

4.37

u/ml

1.87

603

2147

Chronic laryngitis and laryngotracheitis

193

509

3.88

63.91

1.1

1.0

2.61

2.60

u/ml

0.00

181

Bronchitis

1589

5996

1.60

61.57

1.1

5.33

4.82

u/ml

0.40

800

2638

Sleep disorders (combined)

1542

5073

1.60

57.75

1.1

4.63

5.12

u/ml

0.43

694

2364

Migraine

993

4487

1.74

55.58

1.1

5.68

5.49

u/ml

0.07

456

2045

Any reimbursement code in KELA

1166

3467

1.71

54.98

1.1

7.32

4.20

u/ml

3.42

629

1376

Diseases of the eye and adnexa

1368

4245

1.63

54.59

1.1

6.21

5.71

u/ml

0.29

717

1809

1515

4882

1.58

54.20

1.1

5.23

4.95

u/ml

0.17

733

2103

D07AA Corticosteroids, weak (group I)

379

1632

2.39

52.31

1.1

11.85

6.11

u/ml

3.76

272

785

Pain in joint

886

3093

1.78

50.82

1.1

5.86

5.22

u/ml

0.27

444

1441

Asthma and opportunity respiratory infection

8.34

50.60

1.1

1.0

2.10

1.92

u/ml

0.05

Diseases of the skin and subcutaneous tissue

1347

4265

1.60

49.69

1.1

6.62

3.77

u/ml

4.26

698

1763

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1446

6028

1.55

49.45

1.1

4.80

5.26

u/ml

0.39

660

2772

Polypectomy (DHB20)

121

275

4.56

49.28

1.2

1.1

2.49

3.35

u/ml

0.31

112

Other acute lower respiratory infections

775

4173

1.79

49.15

1.1

6.33

5.53

u/ml

0.44

440

1949

Asthma mixed form (mode), excluding more controls

188

5.38

48.71

1.1

5.63

3.18

u/ml

0.77

Early onset COPD, excluding more controls

174

514

3.42

48.47

1.1

1.0

6.34

3.32

u/ml

1.02

104

168

Asthma mixed form (mode)

189

5.36

48.43

1.1

5.63

3.14

u/ml

0.80

Bronchiectasis

130

6.36

48.36

1.1

1.96

2.02

u/ml

0.02

Voice disturbances

369

1635

2.29

47.42

1.1

2.89

3.81

u/ml

0.70

179

690

Personal history of allergy to drugs, medicaments and biological substances

8.44

46.10

1.4

1.1

4.90

6.95

u/ml

0.25

Sleep apnoea

1157

4615

1.59

44.40

1.1

3.20

4.10

u/ml

1.32

515

2043

Other medical care

527

2276

1.96

43.98

1.1

6.13

4.67

u/ml

1.01

333

995

Dentofacial anomalies [including malocclusion]

1166

5958

1.55

40.77

1.1

5.04

4.91

u/ml

0.06

523

2699

Other and unspecified urticaria

377

1804

2.13

40.29

1.1

5.95

6.01

u/ml

0.02

212

818

Symptoms and signs involving speech and voice

404

1982

2.06

40.06

1.1

3.40

3.84

u/ml

0.25

195

846

Acute bronchitis

534

2855

1.85

38.58

1.1

4.85

5.32

u/ml

0.26

289

1308

Dermatitis

742

4357

1.68

38.09

1.1

4.84

3.67

u/ml

0.92

373

1768

Triptan medication for migraine, single purchase ok

1226

5535

1.51

38.05

1.1

6.34

4.92

u/ml

0.92

540

2541

Migraine, single triptan purchase ok & required. ICD-code if available is included

1226

5535

1.51

38.05

1.1

6.34

4.92

u/ml

0.92

540

2541

Headache

1055

5286

1.55

38.00

1.1

5.90

5.23

u/ml

0.37

474

2401

Any death

2177

0.25

37.70

1.0

1.1

2.49

3.20

u/ml

0.36

970

Episodal and paroxysmal disorders

1541

5447

1.44

35.96

1.1

5.35

5.45

u/ml

0.05

715

2538

Recurrent or chronic depression

618

2463

1.76

35.34

1.1

6.09

4.31

u/ml

0.67

292

1100

Gastro-oesophageal reflux disease

836

4425

1.60

35.20

1.1

3.18

4.62

u/ml

1.85

357

1968

Exposure to unspecified factor

1412

6709

1.44

34.42

1.1

5.64

5.05

u/ml

0.50

709

3047

Dermatographic urticaria

159

558

2.95

33.81

1.1

4.13

3.65

u/ml

0.13

239

Mycoses, including avohilmo

1266

6721

1.44

31.83

1.1

4.64

5.03

u/ml

0.29

554

3107

Intestinal infectious diseases, including avohilmo, including avohilmo

1490

5904

1.41

31.64

1.1

4.17

5.32

u/ml

1.58

671

2720

Other inflammation of eyelid, including avohilmo

744

4703

1.60

31.47

1.1

4.86

5.16

u/ml

0.16

352

2136

Special screening examination for infectious and parasitic diseases

533

2226

1.77

31.40

1.1

5.17

5.48

u/ml

0.13

262

923

Coxibs

339

853

2.10

30.99

1.1

8.01

6.38

u/ml

0.34

141

428

Other and unspecified dermatitis

606

3653

1.67

30.93

1.1

4.42

3.71

u/ml

0.48

301

1495

COPD/asthma/ILD related infections

1326

4639

1.44

30.59

1.1

5.46

4.98

u/ml

0.30

633

2020

COPD/asthma related infections

1326

4639

1.44

30.59

1.1

5.46

4.98

u/ml

0.30

633

2020

Triptan medication for migraine, min. 3 purchases

1017

5157

1.49

29.70

1.1

6.22

4.83

u/ml

0.86

432

2327

Other chronic obstructive pulmonary disease

224

788

2.34

29.66

1.1

1.0

5.30

2.25

u/ml

1.44

127

290

COPD

235

843

2.28

29.18

1.1

1.0

5.11

2.28

u/ml

1.36

132

313

Irritable bowel syndrome

416

2305

1.83

28.91

1.1

4.14

4.61

u/ml

0.21

176

1025

Abnormalities of heart beat

414

2217

1.83

28.79

1.1

5.58

4.97

u/ml

0.16

194

961

Pain and other conditions associated with female genital organs and menstrual cycle

436

2039

1.82

28.63

1.1

4.71

6.27

u/ml

0.74

191

959

Idiopathic urticaria

176

4.42

28.05

1.1

3.80

7.34

u/ml

0.68

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

585

1739

1.70

28.02

1.1

5.49

5.79

u/ml

0.13

278

797

Temporomandibular joint disorders, including avohilmo

790

5042

1.53

27.73

1.1

3.85

5.45

u/ml

2.07

381

2235

Acetic acid derivatives and related substances

314

801

2.04

26.64

1.1

4.82

5.56

u/ml

0.26

132

396

Pain in throat and chest

1091

4496

1.44

26.61

1.1

4.81

5.04

u/ml

0.11

478

1986

Abnormal findings on diagnostic imaging of lung

351

1787

1.87

26.48

1.1

3.27

3.25

u/ml

0.01

179

763

Allergic contact dermatitis

217

989

2.24

26.44

1.1

6.97

3.50

u/ml

1.63

109

399

Other disorders of lacrimal gland

423

2448

1.74

25.32

1.1

4.62

4.19

u/ml

0.18

180

1065

Atopic conjunctivitis

106

350

3.14

25.26

1.2

1.1

7.01

6.98

u/ml

0.00

159

Disorders of lacrimal system

499

2985

1.66

24.71

1.1

4.44

4.41

u/ml

0.01

215

1300

Conjunctivitis (acute, non atopic)

414

2390

1.74

24.69

1.1

7.44

6.47

u/ml

0.39

215

1051

Eosinophilic disease (BM)

7.94

24.43

1.2

1.0

2.79

1.52

u/ml

0.36

Anxiety disorders

1246

6276

1.37

23.01

1.1

6.00

4.68

u/ml

0.97

617

2797

Neurotic, stress-related and somatoform disorders

1241

6278

1.37

22.91

1.1

5.98

4.69

u/ml

0.94

617

2798

Exposure to other specified factors

1112

6933

1.38

22.76

1.1

5.70

5.00

u/ml

0.39

552

3169

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1200

6854

1.37

22.70

1.1

5.47

5.11

u/ml

0.27

555

3170

Other headache syndromes

559

3564

1.58

22.58

1.1

6.28

4.61

u/ml

0.56

255

1553

Pain (limb, back, neck, head abdominally)

917

3183

1.45

22.34

1.1

6.15

5.29

u/ml

0.53

445

1505

Codeine

1253

4979

1.37

21.99

1.1

4.69

4.70

u/ml

0.01

578

2209

Malignant neoplasm

529

4804

0.64

21.59

1.1

3.09

4.26

u/ml

1.00

225

2138

Abdominal and pelvic pain

1260

4667

1.36

21.36

1.1

4.90

5.42

u/ml

0.44

595

2189

Other viral diseases, including avohilmo

672

4491

1.50

21.28

1.1

5.91

6.10

u/ml

0.08

328

2146

Depression or dysthymia

735

2699

1.50

21.22

1.1

6.75

4.30

u/ml

1.54

346

1219

Codeine or tramadol medication

1403

5735

1.33

21.14

1.1

4.56

4.65

u/ml

0.05

643

2536

Symptoms and signs involving the digestive system and abdomen

1260

4668

1.36

21.06

1.1

5.02

5.42

u/ml

0.30

593

2190

Other specific joint derangements/joint disorders

1122

5112

1.38

21.05

1.1

5.70

5.33

u/ml

0.17

541

2346

Malignant neoplasm

534

4796

0.65

20.71

1.1

3.14

4.25

u/ml

0.93

227

2130

Diabetes, insulin treatment (Kela reimbursement)

617

5468

0.67

20.69

1.1

4.76

4.37

u/ml

0.20

292

2442

Renal tubulo-interstitial diseases

521

5857

0.65

20.69

1.1

5.74

4.88

u/ml

0.44

240

2666

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

599

5282

0.67

19.92

1.1

4.81

4.46

u/ml

0.17

285

2348

Diabetes medication

762

6332

0.70

19.91

1.1

4.55

4.75

u/ml

0.11

366

2830

Solid cancers

505

4554

0.65

19.90

1.1

3.09

3.98

u/ml

0.63

211

1998

Medical observation and evaluation for suspected diseases and conditions

820

2914

1.45

19.76

1.1

5.21

5.54

u/ml

0.16

442

1227

Simple and mucopurulent chronic bronchitis

4.73

19.66

1.1

1.22

4.76

u/ml

0.81

Tonsillectomy and adenotomy

1049

5363

1.37

19.62

1.1

5.78

5.65

u/ml

0.06

515

2496

Opioids

1319

5145

1.33

19.29

1.1

5.37

4.95

u/ml

0.23

619

2312

Candidiasis, including avohilmo

418

2605

1.62

19.06

1.1

4.45

5.30

u/ml

0.36

184

1197

Caries of enamel

1248

6174

1.33

18.91

1.1

5.03

5.07

u/ml

0.03

593

2781

Propionic acid derivatives

344

990

1.76

18.85

1.1

5.97

6.98

u/ml

0.37

160

517

All anxiety disorders

1002

5721

1.37

18.84

1.1

5.35

4.82

u/ml

0.37

509

2558

Migraine with aura

438

2779

1.59

18.56

1.1

6.48

5.34

u/ml

0.28

208

1246

Bronchitis, not specified as acute or chronic

338

2.79

18.55

1.1

1.0

6.07

2.61

u/ml

1.01

128

Other special examinations and investigations of persons without complaint or reported diagnosis

818

2914

1.43

18.55

1.1

4.65

5.54

u/ml

0.66

430

1227

All kidney diseases

718

6806

0.70

18.51

1.1

5.10

5.03

u/ml

0.04

341

3103

Low back pain

1009

5016

1.36

18.38

1.1

4.61

4.87

u/ml

0.15

458

2268

Malignant neoplasm, wide definition

587

4996

0.68

17.95

1.1

2.98

4.49

u/ml

1.69

257

2241

Any event in cancer register

680

5641

0.70

17.71

1.1

3.52

4.65

u/ml

1.11

290

2541

Malignant neoplasm, including Hilmo

591

5008

0.68

17.61

1.1

2.99

4.48

u/ml

1.70

259

2241

Diabetes, varying definitions

781

6279

0.72

17.57

1.1

4.96

4.76

u/ml

0.10

374

2808

Dorsalgia

1294

5243

1.31

17.49

1.1

5.49

4.96

u/ml

0.32

591

2389

Other dorsopathies, not elsewhere classified

1324

5277

1.31

17.39

1.1

5.67

5.01

u/ml

0.44

623

2407

Diabetes mellitus

791

6301

0.72

17.22

1.1

4.99

4.75

u/ml

0.12

381

2819

Other soft tissue disorders, not elsewhere classified

1234

5362

1.31

17.05

1.1

4.88

5.58

u/ml

0.48

558

2508

Schizophrenia

1326

0.25

16.97

1.1

11.09

3.90

u/ml

0.65

606

Eosinophilia

5.39

16.93

1.2

1.0

2.79

5.85

u/ml

0.52

Parasetamol

1042

3919

1.35

16.92

1.1

5.27

5.32

u/ml

0.02

489

1816

Diseases of middle ear and mastoid

892

5363

1.37

16.91

1.1

6.32

5.53

u/ml

0.40

449

2512

Solid cancers, including Hilmo

566

4792

0.68

16.77

1.1

3.01

4.20

u/ml

1.13

241

2120

Cystitis

1012

4489

1.35

16.66

1.1

4.24

5.13

u/ml

0.83

432

2051

Other viral diseases, not elsewhere classified, including avohilmo

462

3027

1.53

16.57

1.1

6.87

6.38

u/ml

0.16

219

1468

Neurological diseases

1210

4638

1.32

16.47

1.1

6.02

5.68

u/ml

0.16

562

2190

Myalgia

327

1994

1.66

16.38

1.1

5.01

5.07

u/ml

0.01

147

886

Other joint disorders

1299

5232

1.30

16.34

1.1

6.11

5.41

u/ml

0.40

621

2410

Heartburn

147

699

2.13

16.28

1.0

1.1

3.78

4.79

u/ml

0.32

306

Anxiety (asthma-related co-morbidities)

959

5452

1.34

16.24

1.1

5.23

4.70

u/ml

0.37

486

2406

Allergic urticaria

149

715

2.13

16.23

1.2

1.1

7.53

5.63

u/ml

0.42

330

Anxiety disorders, excluding more controls

1075

5212

1.32

15.96

1.1

5.26

4.54

u/ml

0.45

531

2279

Dorsopathies

1361

5369

1.29

15.93

1.1

5.37

5.10

u/ml

0.16

650

2473

Diseases of the musculoskeletal system and connective tissue

881

3241

1.37

15.74

1.1

6.44

5.85

u/ml

0.27

437

1548

Dermatophytosis, including avohilmo

791

5689

1.37

15.65

1.1

4.77

4.83

u/ml

0.03

350

2582

Other antidepressants

1192

4670

1.31

15.63

1.1

6.17

4.43

u/ml

1.30

559

2094

COPD (mode)

129

452

2.23

15.53

1.1

1.0

5.77

2.98

u/ml

0.67

158

Other chronic obstructive pulmonary disease, including avohilmo

326

1638

1.64

15.49

1.1

4.76

3.45

u/ml

0.63

180

706

Soft tissue disorders

1363

5461

1.28

15.48

1.1

4.74

5.63

u/ml

0.78

639

2561

Pruritus

143

691

2.10

15.21

1.1

3.57

2.60

u/ml

0.27

273

Migraine with aura and triptan purchases

305

1867

1.66

15.21

1.1

7.14

4.65

u/ml

0.50

148

864

Anti-inflammatory and antirheumatic products, non-steroids

327

991

1.67

15.03

1.1

6.39

6.99

u/ml

0.19

155

518

Insulin medication

281

3804

0.61

15.02

1.1

4.63

4.81

u/ml

0.07

140

1762

Other bacterial diseases

593

5527

0.71

14.90

1.1

4.49

4.99

u/ml

0.30

302

2497

Biguanides

596

5061

0.71

14.78

1.1

4.27

3.99

u/ml

0.14

276

2175

Diseases of the ear and mastoid process

1487

5924

1.26

14.76

1.1

5.67

5.02

u/ml

0.48

705

2676

Dysphagia

207

1145

1.82

14.71

1.1

1.0

4.21

3.41

u/ml

0.29

494

Nonsuppurative otitis media, including avohilmo

561

3409

1.44

14.32

1.1

5.73

6.28

u/ml

0.26

288

1638

Fenamates

150

502

2.05

14.10

1.1

2.99

4.54

u/ml

0.60

241

Certain infectious and parasitic diseases, including avohilmo

866

3231

1.35

14.06

1.1

4.68

5.13

u/ml

0.27

403

1477

Diseases of oesophagus, stomach and duodenum

1255

5828

1.28

14.04

1.1

3.91

4.95

u/ml

0.97

568

2643

Neurological diseases, wide definition

554

1923

1.46

14.03

1.1

6.32

u/ml

0.00

271

958

Other (not insulin) diabetes medications

650

5243

0.72

13.97

1.1

4.14

3.94

u/ml

0.10

306

2262

Early onset COPD

174

928

1.89

13.94

1.1

1.0

6.34

3.16

u/ml

1.19

104

390

Type 2 diabetes

711

5576

0.73

13.90

1.1

5.01

4.10

u/ml

0.57

334

2424

Haemorrhage from respiratory passages

241

1248

1.72

13.83

1.1

1.0

4.01

4.40

u/ml

0.12

114

534

Herpesviral [herpes simplex] infections, including avohilmo

384

2534

1.53

13.83

1.1

6.04

4.91

u/ml

0.53

180

1131

Schizophrenia or delusion

156

2897

0.53

13.81

1.1

6.27

4.81

u/ml

0.35

1330

Schizophrenia, schizotypal and delusional disorders

157

2899

0.54

13.64

1.1

6.20

4.81

u/ml

0.33

1331

Later onset COPD, excluding more controls

107

3.50

13.55

1.0

0.60

3.04

u/ml

0.74

Disorders of synovium and tendon

639

3929

1.39

13.51

1.1

3.70

4.75

u/ml

0.93

280

1732

Functional dyspepsia

292

1819

1.62

13.50

1.1

3.31

4.44

u/ml

0.66

134

793

Selective serotonin reuptake inhibitors

1167

4746

1.28

13.38

1.1

6.14

4.55

u/ml

1.28

537

2149

Type 2 diabetes, strict (exclude DM1)

647

5135

0.73

13.26

1.1

5.08

3.91

u/ml

0.71

302

2210

Soft tissue disorders related to use, overuse and pressure

257

1561

1.66

13.14

1.1

3.22

3.72

u/ml

0.29

116

662

Paracetamol or NSAID medication

235

678

1.76

13.12

1.1

7.18

7.49

u/ml

0.07

123

358

Acute bronchiolitis

168

819

1.90

13.06

1.2

1.1

11.64

10.11

u/ml

0.23

112

456

Hyperkinetic disorders, excluding more controls

335

2032

1.56

12.98

1.1

8.94

6.27

u/ml

0.83

176

1011

Migraine without aura

381

2547

1.51

12.98

1.1

4.22

5.62

u/ml

0.86

180

1174

Other respiratory diseases principally affecting the interstitium

106

487

2.19

12.84

1.1

1.49

3.39

u/ml

1.41

220

Type 2 diabetes, definitions combined

650

5125

0.73

12.79

1.1

5.05

3.92

u/ml

0.68

304

2205

ILD, hospital admissions 1, main diag only

351

2.41

12.72

1.1

1.22

2.86

u/ml

1.26

157

Migraine without aura and triptan purchases

308

1987

1.57

12.43

1.1

4.06

4.99

u/ml

0.40

137

927

Other menopausal disorders

282

967

1.64

12.40

1.0

1.1

2.92

2.95

u/ml

0.02

125

408

Other anxiety disorders

764

4923

1.33

12.26

1.1

5.99

5.02

u/ml

0.64

392

2223

Examination and observation for other reasons

696

2902

1.36

12.25

1.1

4.36

5.52

u/ml

0.97

328

1221

Other inflammation of eyelid

159

862

1.86

12.22

1.1

3.52

4.17

u/ml

0.20

378

Gastrointestinal diseases

916

3527

1.31

12.12

1.1

4.95

6.00

u/ml

0.87

423

1662

Suppurative and unspecified otitis media

632

4137

1.36

12.07

1.1

7.85

5.89

u/ml

0.90

324

1991

Disease of hard tissues of teeth, NOS

525

1938

1.42

12.04

1.1

4.10

4.17

u/ml

0.03

253

801

Non-allergic asthma

348

2.38

12.04

1.1

1.0

1.33

3.51

u/ml

1.37

134

Disorders of eyelid, lacrimal system and orbit

927

5275

1.29

11.99

1.1

4.66

4.78

u/ml

0.06

411

2358

Lower back pain or/and sciatica

1272

6360

1.25

11.94

1.1

5.08

4.72

u/ml

0.20

573

2863

Kela-code for severe mental illness

193

3242

0.59

11.92

1.1

5.87

4.55

u/ml

0.38

104

1483

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

539

3380

1.39

11.87

1.1

3.05

4.15

u/ml

1.00

267

1472

Depression

1188

6357

1.25

11.83

1.1

6.47

4.51

u/ml

1.63

584

2829

Transport accidents

612

3752

1.36

11.78

1.1

4.51

4.66

u/ml

0.08

279

1655

Disturbance of activity and attention

341

2233

1.51

11.56

1.1

8.84

7.06

u/ml

0.50

183

1146

Injuries to the wrist and hand

1255

6723

1.24

11.47

1.1

5.97

4.94

u/ml

0.81

600

3088

Schizophrenia or delusion, excluding more controls

156

2705

0.57

11.45

1.1

6.27

4.45

u/ml

0.46

1212

Inflammatory diseases of female pelvic organs

861

4559

1.30

11.45

1.1

5.46

4.83

u/ml

0.29

374

2001

Type 2 diabetes, wide definition

387

3527

0.69

11.42

1.1

3.20

3.46

u/ml

0.13

191

1485

Depression medications

592

2165

1.39

11.40

1.1

8.95

5.22

u/ml

1.90

279

992

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

309

2042

1.53

11.21

1.1

8.77

5.19

u/ml

0.95

134

922

Insulin, combination of fast acting with intermediate-acting or long-acting

281

3877

0.65

11.18

1.1

4.63

4.90

u/ml

0.10

140

1797

ILD, hospital admissions

405

2.21

11.12

1.1

1.19

3.09

u/ml

1.46

186

Hyperkinetic disorders

350

2324

1.49

11.04

1.1

8.96

7.18

u/ml

0.51

189

1192

Persons encountering health services for examination and investigation

765

2914

1.32

11.02

1.1

3.95

5.54

u/ml

1.49

377

1227

Other interstitial pulmonary diseases

407

2.20

10.99

1.1

1.19

3.07

u/ml

1.45

187

Internal derangement of knee

409

2834

1.44

10.96

1.1

5.09

4.52

u/ml

0.23

185

1233

Interstitial lung disease

408

2.20

10.92

1.1

1.19

3.07

u/ml

1.45

187

Interstitial lung disease endpoints

408

2.20

10.92

1.1

1.19

3.07

u/ml

1.45

187

Acne, including avohilmo

504

2955

1.40

10.92

1.1

4.85

6.60

u/ml

1.44

230

1478

Other diseases of lip and oral mucosa

439

3124

1.41

10.76

1.1

4.13

4.87

u/ml

0.37

206

1374

Accidents

995

3932

1.27

10.75

1.1

6.00

4.79

u/ml

0.80

480

1732

Inflammatory diseases of prostate (prostatitis)

457

2.12

10.74

1.1

1.0

1.99

3.69

u/ml

0.89

214

Type 2 diabetes, definitions combined, including avohilmo

682

5169

0.76

10.71

1.1

4.86

3.95

u/ml

0.54

321

2221

Cerebrovascular diseases

252

2703

0.64

10.64

1.1

3.27

3.17

u/ml

0.04

1165

Restless leg syndrome

152

852

1.80

10.56

1.1

5.72

3.71

u/ml

0.50

368

Other bacterial diseases, including avohilmo

795

6355

0.78

10.52

1.1

4.76

5.04

u/ml

0.19

411

2862

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

305

2.18

10.48

1.1

1.32

3.23

u/ml

1.32

135

Allergic colitis

377

2.28

10.36

1.1

9.47

10.36

u/ml

0.12

215

COPD, early/later onset

225

1182

1.60

10.01

1.1

1.0

5.26

2.97

u/ml

0.97

128

495

COPD, hospital admissions

223

1174

1.61

9.99

1.1

1.0

5.19

3.00

u/ml

0.90

127

490

Persons encountering health services for specific procedures and health care

1344

6549

1.21

9.87

1.1

5.44

5.04

u/ml

0.25

731

2915

Renal failure

100

1633

0.52

9.86

1.1

6.71

3.94

u/ml

0.60

736

Malignant neoplasm of breast

208

2124

0.63

9.82

1.1

2.75

3.30

u/ml

0.30

859

Diaphragmatic hernia

240

1544

1.56

9.79

1.1

1.68

2.90

u/ml

1.57

127

647

All chronic kidney diseases

237

2897

0.65

9.78

1.1

7.17

5.22

u/ml

0.64

116

1359

Other and unspecified nonorganic psychotic disorders

113

2068

0.54

9.75

1.1

6.19

5.24

u/ml

0.17

959

Oxicams

168

546

1.76

9.74

1.1

3.19

4.28

u/ml

0.41

267

Malignant neoplasm of breast, HER2-negative

209

2121

0.63

9.60

1.1

2.80

3.30

u/ml

0.27

858

Arthropathies

1271

5277

1.22

9.60

1.1

5.59

5.51

u/ml

0.04

611

2445

Visual disturbances

496

3674

1.36

9.57

1.1

6.16

5.05

u/ml

0.40

246

1676

Other external causes of accidental injury

982

3932

1.26

9.57

1.1

6.18

4.79

u/ml

0.93

474

1732

Peritonsillar abscess

225

1437

1.58

9.54

1.1

1.0

5.00

4.98

u/ml

0.01

106

567

Malignant neoplasm of breast, including Hilmo

219

2182

0.64

9.54

1.1

2.53

3.40

u/ml

0.59

879

Acute pharyngitis

265

1744

1.52

9.43

1.1

7.35

6.49

u/ml

0.22

127

835

Malignant neoplasm of breast, HER2-negative, including Hilmo

220

2182

0.64

9.38

1.1

2.58

3.40

u/ml

0.55

879

Vocal cord dysfunction

188

1013

1.65

9.35

1.2

1.1

2.75

4.22

u/ml

0.94

429

Enthesopathies of lower limb, excluding foot

256

1691

1.52

9.34

1.0

1.1

4.36

4.29

u/ml

0.02

121

719

Excessive attrition of teeth

796

6241

1.27

9.32

1.1

4.37

5.11

u/ml

0.54

375

2821

Other diseases of oesophagus

338

2.21

9.25

1.1

1.79

3.71

u/ml

1.15

158

Intestinal infectious diseases

1128

6876

1.22

9.24

1.1

4.33

5.35

u/ml

1.27

557

3151

Unspecified mental disorder

257

3814

0.67

9.24

1.1

5.51

4.96

u/ml

0.16

136

1739

Lichen simplex chronicus and prurigo

251

2.42

9.23

1.1

4.53

2.84

u/ml

0.38

100

Acute suppurative otitis media

499

3472

1.35

9.17

1.1

6.02

6.26

u/ml

0.09

256

1698

Cervicocranial syndrome

119

648

1.86

9.16

1.1

3.95

4.04

u/ml

0.02

280

Stroke, including SAH

173

2014

0.61

9.15

1.1

2.99

3.25

u/ml

0.09

880

ILD, hospital admission 2, with pulmonary infections

216

2.52

9.10

1.1

1.43

3.29

u/ml

0.79

Endometriosis of pelvic peritoneum

224

1312

1.57

9.09

1.1

2.72

4.73

u/ml

1.70

594

Periodontitis

697

5664

0.78

9.01

1.1

3.99

4.12

u/ml

0.08

334

2476

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

109

581

1.90

9.00

1.1

4.02

4.70

u/ml

0.20

260

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

408

2964

1.39

8.99

1.1

4.97

5.28

u/ml

0.14

204

1372

Mouth breathing

395

2849

1.39

8.96

1.1

3.87

5.43

u/ml

1.11

194

1336

Injuries to the ankle and foot

988

6865

1.23

8.95

1.1

5.78

5.17

u/ml

0.40

487

3136

Other diseases of intestines

1374

6392

1.20

8.93

1.1

4.62

5.43

u/ml

0.82

606

2999

Dislocation, sprain and strain of joints and ligaments of knee

811

5845

1.26

8.92

1.1

5.35

4.77

u/ml

0.23

381

2600

Mental and behavioural disorders due to alcohol, excluding acute intoxication

209

3183

0.65

8.90

1.1

3.93

4.39

u/ml

0.18

114

1439

External causes of morbidity and mortality

837

3321

1.27

8.90

1.1

6.48

4.53

u/ml

1.27

396

1471

COPD, hospital admissions 1, only main diagnosis

155

784

1.70

8.86

1.1

3.53

3.15

u/ml

0.11

342

Insulin, intermediate and long-acting

249

3557

0.67

8.81

1.1

5.08

4.84

u/ml

0.08

124

1648

Alcohol use disorder, ICD-based

190

2971

0.64

8.79

1.1

4.08

4.45

u/ml

0.12

103

1340

Mood [affective] disorders

1204

6384

1.21

8.78

1.1

6.28

4.52

u/ml

1.41

591

2848

Codes for special purposes

600

4586

1.30

8.76

1.1

5.00

5.33

u/ml

0.17

308

2119

Alcohol dependence

1602

0.51

8.75

1.1

3.79

3.72

u/ml

0.01

699

Trochanteric bursitis

129

730

1.78

8.75

1.1

1.56

3.71

u/ml

2.22

296

Chronic periodontitis, including avohilmo

698

5652

0.78

8.70

1.1

3.99

4.13

u/ml

0.08

334

2470

Provisional assignment of new diseases of uncertain etiology

599

4584

1.30

8.68

1.1

5.00

5.34

u/ml

0.17

308

2118

Other and unspecified tonsillitis

556

3524

1.32

8.67

1.1

5.69

5.54

u/ml

0.05

262

1645

Visual disturbances and blindness

514

3883

1.33

8.66

1.1

5.99

5.02

u/ml

0.35

255

1784

Mood disorders

1204

6383

1.21

8.65

1.1

6.27

4.52

u/ml

1.39

592

2846

Organic, including symptomatic, mental disorders

1130

0.51

8.62

1.0

1.1

2.02

3.05

u/ml

0.57

500

360

4320

0.72

8.49

1.1

4.07

4.98

u/ml

0.61

192

1945

Subjective visual disturbances

266

1814

1.48

8.36

1.1

5.95

4.95

u/ml

0.32

131

806

Excessive, frequent and irregular menstruation

526

2115

1.34

8.34

1.1

4.44

6.30

u/ml

1.24

246

999

Pain in limb

998

5182

1.23

8.34

1.1

4.51

5.61

u/ml

1.04

451

2412

Viral warts, including avohilmo

317

2239

1.43

8.31

1.1

4.87

6.27

u/ml

0.78

123

1086

Acute tubulo-interstitial nephritis

374

4307

0.73

8.21

1.1

5.19

4.98

u/ml

0.07

169

1972

Other noninfective gastroenteritis and colitis

279

1928

1.46

8.17

1.1

5.64

6.47

u/ml

0.30

148

938

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

492

3255

1.33

8.12

1.1

8.81

6.71

u/ml

0.82

252

1640

Oesophagitis

205

2.47

8.08

1.1

2.80

4.42

u/ml

0.40

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

873

0.38

8.08

1.0

1.1

1.33

3.44

u/ml

1.69

350

Substance abuse

361

4582

0.73

8.07

1.1

5.58

4.73

u/ml

0.44

199

2063

Other general symptoms and signs

520

1.90

8.06

1.2

1.1

4.99

7.40

u/ml

0.50

268

333

4112

0.72

8.02

1.1

4.14

5.02

u/ml

0.55

182

1864

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

971

4639

1.23

7.99

1.1

4.50

4.98

u/ml

0.37

505

2020

971

4639

1.23

7.99

1.1

4.50

4.98

u/ml

0.37

505

2020

Dermatitis due to substances taken internally

308

2.18

7.94

1.0

1.1

8.06

4.12

u/ml

0.74

120

Mental and behavioural disorders due to psychoactive substance use

380

4703

0.74

7.90

1.1

5.47

4.79

u/ml

0.35

206

2117

Other disorders of adrenal gland

309

2.18

7.90

1.2

1.1

3.50

6.30

u/ml

0.59

144

Stroke, excluding SAH

155

1793

0.62

7.87

1.1

2.75

3.39

u/ml

0.25

782

Emphysema

105

3.07

7.85

1.2

1.1

1.56

1.72

u/ml

0.04

Female infertility, cervical, vaginal, other or unspecified origin

380

1771

1.38

7.77

1.1

5.58

5.06

u/ml

0.18

164

806

Vasomotor rhinitis (mode)

378

2.04

7.73

1.1

8.01

4.42

u/ml

0.36

169

Heart failure, not strict

313

2931

0.72

7.71

1.1

3.99

3.84

u/ml

0.05

149

1294

Diseases of external ear

353

2574

1.38

7.66

1.1

7.78

5.42

u/ml

0.67

167

1202

Dipeptidyl peptidase 4 (DPP-4) inhibitors

157

1951

0.63

7.66

1.0

1.1

6.49

2.81

u/ml

1.00

830

Other nutritional deficiencies

818

6074

1.23

7.62

1.1

5.08

4.76

u/ml

0.14

380

2700

COPD related to multimorbidity

163

861

1.60

7.45

1.1

3.19

2.23

u/ml

0.43

359

Alcohol use disorder, Swedish definition

295

3730

0.72

7.42

1.1

3.64

4.49

u/ml

0.52

159

1671

Mental and behavioural disorders due to alcohol

290

3849

0.71

7.40

1.1

4.59

4.79

u/ml

0.08

158

1739

Unspecified chronic bronchitis

3.77

7.36

1.2

1.1

4.76

3.43

u/ml

0.16

Fibromyalgia

127

755

1.70

7.36

1.1

3.71

3.46

u/ml

0.07

307

Female infertility

412

1837

1.35

7.34

1.1

5.85

5.43

u/ml

0.15

177

843

Spondylolisthesis/Spondylolysis

157

985

1.60

7.31

1.0

2.24

4.13

u/ml

1.61

414

Mood disorders, excluding more controls

1066

5218

1.20

7.30

1.1

6.19

4.37

u/ml

1.26

520

2280

Other enthesopathies

303

2173

1.40

7.28

1.1

3.27

3.95

u/ml

0.26

123

914

Other extrapyramidal and movement disorders in other diseases

200

1327

1.52

7.26

1.1

4.80

3.73

u/ml

0.32

573

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

167

1052

1.59

7.23

1.2

1.1

6.85

7.63

u/ml

0.17

556

Oedema, not elsewhere classified

275

1895

1.42

7.23

1.1

2.99

4.14

u/ml

0.99

136

849

Injuries to the knee and lower leg

1407

6489

1.17

7.20

1.1

5.31

5.07

u/ml

0.13

657

2962

Drug-induced adrenocortical insufficiency

106

3.01

7.20

1.2

1.1

5.45

4.04

u/ml

0.11

Acute laryngitis and tracheitis

223

1495

1.48

7.19

1.1

5.66

7.16

u/ml

0.60

124

733

Chronic gastritis

145

896

1.62

7.16

1.1

5.96

4.02

u/ml

0.22

364

Unspecified privation

116

678

1.73

7.15

1.1

2.18

4.56

u/ml

2.35

309

Substance abuse, excluding more controls

361

4045

0.74

7.13

1.1

5.58

4.36

u/ml

0.73

199

1796

Other viral diseases

432

3279

1.32

7.08

1.1

7.06

6.33

u/ml

0.26

219

1599

STROKE

280

2633

0.71

7.07

1.0

1.1

2.84

3.59

u/ml

0.51

122

1125

COPD, hospital admission 2, with asthma infections

145

770

1.63

7.04

1.1

5.50

3.04

u/ml

0.69

334

Exfoliative dermatitis

6.02

6.99

1.1

24.10

0.69

u/ml

2.35

Otalgia

115

676

1.72

6.97

1.2

1.1

6.65

6.83

u/ml

0.03

334

Psychiatric diseases

1072

4485

1.20

6.96

1.1

6.40

4.62

u/ml

1.41

514

2028

Otitis externa

260

1837

1.42

6.88

1.1

7.17

5.54

u/ml

0.29

116

853

Disturbances of skin sensation

341

2526

1.36

6.78

1.1

4.43

4.76

u/ml

0.12

149

1120

Adenomyosis (Endometriosis of uterus)

127

770

1.66

6.78

1.1

2.10

3.60

u/ml

1.12

331

Somatoform disorder

199

1346

1.49

6.66

1.1

5.93

4.55

u/ml

0.19

588

Ganglion

249

1757

1.43

6.65

1.1

3.13

5.28

u/ml

2.01

112

768

Symptoms and signs involving the skin and subcutaneous tissue

765

5923

1.22

6.64

1.1

5.03

4.81

u/ml

0.11

344

2667

Other degenerative diseases of the nervous system

998

0.54

6.61

1.0

1.1

1.84

3.43

u/ml

1.20

427

Other diseases of hard tissues of teeth

493

1970

1.30

6.61

1.1

4.57

4.17

u/ml

0.18

229

824

Acute appendicitis, no complications

677

5460

1.24

6.59

1.0

1.1

4.97

4.48

u/ml

0.27

286

2442

Cervicalgia

192

1291

1.50

6.59

1.1

3.77

4.22

u/ml

0.18

544

Generalized anxiety disorder

293

2129

1.39

6.59

1.1

5.77

5.24

u/ml

0.17

149

986

Appendicitis, broad definition

835

6205

1.21

6.52

1.1

4.64

4.48

u/ml

0.09

355

2764

Any gastric operation

1100

4651

1.19

6.51

1.1

4.69

5.79

u/ml

1.12

512

2204

GASTRO-related operations

1100

4651

1.19

6.51

1.1

4.69

5.79

u/ml

1.12

512

2204

General symptoms and signs

1294

5539

1.17

6.49

1.1

5.29

5.17

u/ml

0.06

598

2535

Diseases of appendix

838

6212

1.21

6.47

1.1

4.64

4.47

u/ml

0.10

355

2769

ILD, hospital admissions 3, with pneumonia sepsis

190

2.33

6.40

1.1

1.43

2.66

u/ml

0.56

Ocular pain

112

671

1.69

6.37

1.1

3.94

4.72

u/ml

0.17

303

Irregular menses

729

4486

1.23

6.29

1.1

3.85

5.27

u/ml

1.46

311

1968

Dislocation, sprain and strain of joints and ligaments at neck level

228

1603

1.44

6.28

1.1

6.40

5.21

u/ml

0.31

106

732

Urinary track infection

825

3406

1.22

6.26

1.1

4.92

5.29

u/ml

0.21

373

1538

Malignant neoplasm of digestive organs, including Hilmo

113

1351

0.61

6.24

1.0

1.1

2.65

3.37

u/ml

0.36

584

Diseases of salivary glands

331

2475

1.34

6.22

1.1

4.48

4.82

u/ml

0.11

146

1103

Tinnitus

200

1374

1.46

6.19

1.1

5.15

3.62

u/ml

0.44

599

Unspecified acute lower respiratory infection

159

1043

1.54

6.18

1.1

4.78

4.77

u/ml

0.00

457

Seborrhoeic dermatitis

475

1.80

6.16

1.1

2.41

2.49

u/ml

0.03

200

Malignant neoplasm of breast, ER-positive, including Hilmo

139

1596

0.64

6.12

1.1

2.51

3.18

u/ml

0.34

635

Non-invasive ventilation

293

1855

1.37

6.12

1.1

2.81

4.73

u/ml

2.22

172

812

Ischaemic Stroke, excluding all haemorrhages

139

1580

0.65

6.10

1.1

2.53

3.29

u/ml

0.29

682

Follow-up examination after treatment for conditions other than malignant neoplasms

470

2442

1.29

6.10

1.1

4.16

5.57

u/ml

1.08

210

997

Infections with a predominantly sexual mode of transmission, including avohilmo

655

4888

1.23

6.08

1.1

6.32

5.48

u/ml

0.46

305

2255

Other and unspecified drugs and medicaments

515

1.77

6.05

1.1

4.06

5.04

u/ml

0.26

232

Other diseases of urinary system

1069

5089

1.18

6.03

1.1

4.48

5.24

u/ml

0.67

473

2350

Malignant neoplasm of breast, HER-positive

139

1591

0.65

6.01

1.1

2.51

3.17

u/ml

0.33

631

Disorders of tooth development and eruption

223

1275

1.43

5.98

1.1

5.47

4.78

u/ml

0.17

552

Autoimmune diseases excluding thyroid diseases, strict definition

928

5987

0.84

5.98

1.1

4.64

5.44

u/ml

0.72

435

2818

Autoimmune diseases excluding thyroid diseases

951

6091

0.84

5.87

1.1

4.57

5.41

u/ml

0.80

443

2852

Adrenocortical insufficiency

218

2.19

5.86

1.1

4.18

4.85

u/ml

0.08

Acute appendicitis

791

6121

1.20

5.84

1.0

1.1

4.60

4.43

u/ml

0.09

338

2731

Any dementia

482

0.40

5.80

1.0

1.1

0.17

1.58

u/ml

4.20

216

Superficial injury of lower leg

309

2314

1.34

5.79

1.1

8.46

5.63

u/ml

0.70

145

1059

Noninfective enteritis and colitis

511

4081

1.26

5.76

1.1

5.79

5.43

u/ml

0.16

249

1906

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

863

6616

1.19

5.76

1.1

5.17

5.36

u/ml

0.12

422

3018

Peripheral artery disease

943

0.54

5.76

1.1

1.00

2.61

u/ml

2.73

415

Any dementia, excluding more controls

477

0.40

5.76

1.0

1.1

0.17

1.53

u/ml

3.84

212

Hypertrophy of breast in women and men

230

1646

1.41

5.75

1.1

5.47

4.44

u/ml

0.27

708

Nonorganic sleeping disorders, excluding more controls

290

2157

1.35

5.71

1.1

6.27

4.71

u/ml

0.69

133

964

Deforming dorsopathies

279

2061

1.36

5.70

1.0

1.1

6.00

5.56

u/ml

0.08

130

913

Erysipelas, including avohilmo

421

3974

0.78

5.70

1.0

1.1

4.97

3.89

u/ml

0.80

233

1732

Other symptoms and signs involving the circulatory and respiratory systems

315

1.95

5.68

1.1

4.42

4.80

u/ml

0.06

133

Dementia, including avohilmo

660

0.49

5.68

1.0

1.1

1.41

2.10

u/ml

0.29

298

Pulmonary eosinophilia, not elsewhere classified

5.15

5.61

1.1

1.0

0.79

0.92

u/ml

0.09

Pain in thoracic spine

167

1133

1.48

5.58

1.1

7.09

4.61

u/ml

0.57

483

Cervical disc disorders

269

1987

1.36

5.52

1.1

3.28

3.55

u/ml

0.11

113

818

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

704

4529

1.21

5.50

1.1

3.74

4.42

u/ml

0.54

277

1953

Other disorders of urethra and urinary system

723

4170

1.21

5.50

1.1

4.93

4.87

u/ml

0.02

310

1880

Chondrocostal junction syndrome [Tietze]

211

2.17

5.48

1.1

6.16

7.43

u/ml

0.17

Diarrhoea and gastroenteritis of presumed infectious origin

831

6251

1.19

5.47

1.1

4.21

5.47

u/ml

1.45

415

2878

COPD-related respiratory insufficiency

237

2.08

5.46

1.1

1.94

1.45

u/ml

0.26

105

Degenerative diseases of the nervous system

435

0.38

5.45

1.0

1.1

0.20

1.51

u/ml

—

194

4.91

5.44

1.2

1.1

1.20

1.21

u/ml

—

Other contact dermatitis

472

1.75

5.44

1.1

8.09

2.63

u/ml

1.43

182

Cerebrovascular diseases (FINNGEN)

177

1782

0.69

5.43

1.1

3.33

3.94

u/ml

0.22

754

Covid-19 confirmed case

323

2456

1.32

5.40

1.1

4.42

4.91

u/ml

0.18

164

1123

Fissure and fistula of anal and rectal regions

225

1622

1.39

5.40

1.1

5.31

3.81

u/ml

0.41

711

Nummular dermatitis

307

1.94

5.39

1.1

1.78

3.13

u/ml

0.59

118

Spinal osteochondrosis

3.28

5.38

1.1

1.0

19.39

3.59

u/ml

0.38

Condition for Implicit Sepsis (Organ dysfunction codes)

608

5122

0.82

5.37

1.1

4.51

4.91

u/ml

0.23

286

2330

Anomalies of dental arch relationship, including avohilmo

316

2171

1.33

5.36

1.1

8.49

6.68

u/ml

0.41

155

1081

Faecal incontinence

322

1.91

5.34

1.1

1.0

2.45

2.58

u/ml

0.03

126

Noninflammatory disorders of female genital tract

531

2136

1.25

5.34

1.1

5.55

6.31

u/ml

0.32

241

1012

Rosacea

139

918

1.53

5.32

1.1

5.10

3.67

u/ml

0.45

389

Unspecific neurodegenerative disorder

469

0.42

5.32

1.0

1.1

1.82

1.62

u/ml

0.04

217

Candidiasis

154

1039

1.49

5.32

1.1

5.23

3.69

u/ml

0.37

470

Diagnoses used for exclusion with ILD

170

1169

1.46

5.30

1.1

2.25

3.83

u/ml

1.05

504

Ovarian cyst

423

1896

1.28

5.27

1.1

4.73

5.81

u/ml

0.55

198

873

Other diseases of the respiratory system

109

683

1.60

5.22

1.1

2.06

4.42

u/ml

2.08

312

Other respiratory disorders and diseases

109

683

1.60

5.22

1.1

2.06

4.42

u/ml

2.08

312

Xerosis cutis

3.40

5.19

1.1

1.30

5.82

u/ml

0.66

Blepharochalasis

151

1019

1.49

5.18

1.1

1.56

2.83

u/ml

1.20

412

ILD-related respiratory insufficiency

3.37

5.17

1.2

1.1

1.00

2.87

u/ml

—

Chronic conjunctivitis

177

2.24

5.17

1.1

3.31

6.49

u/ml

0.82

Hypothyroidism, other/unspecified

951

5337

1.17

5.16

1.1

4.00

4.96

u/ml

0.65

394

2415

Disorders of the thyroid gland

1015

5650

1.17

5.14

1.1

4.18

5.01

u/ml

0.54

431

2570

Other and unspecified vaccines and biological substances

3.45

5.13

1.1

3.10

11.85

u/ml

1.23

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

485

3902

1.24

5.10

1.1

4.16

4.06

u/ml

0.04

239

1696

Lichen simplex chronicus

140

2.39

5.09

1.1

5.84

2.43

u/ml

0.43

Sub-endpoint used in defining T1D endpoints

173

2413

0.70

5.09

1.1

5.05

5.69

u/ml

0.22

1168

Malaise and fatigue

486

3078

1.25

5.07

1.1

4.18

4.74

u/ml

0.28

232

1428

Striking against or struck by other objects

429

3417

1.26

5.03

1.1

4.81

6.09

u/ml

0.85

205

1663

Valvular heart disease excluding rheumatic fever

177

1789

0.70

5.02

1.1

2.75

5.04

u/ml

2.25

811

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

883

6525

0.85

4.99

1.1

4.89

5.08

u/ml

0.09

421

2985

Benign neoplasm: Colon, unspecified

123

802

1.54

4.98

1.1

2.85

2.94

u/ml

0.03

333

Occupational exposure to risk-factors

148

2.33

4.96

1.1

0.55

3.04

u/ml

2.58

Selective deficiency of immunoglobulin G [IgG] subclasses

4.76

4.95

1.0

1.1

1.86

2.06

u/ml

—

Acute renal failure

767

0.48

4.93

1.0

1.1

5.37

4.13

u/ml

0.15

349

Infective dermatitis

547

1.66

4.92

1.2

1.1

8.71

3.10

u/ml

1.12

211

Other disorders of eye and adnexa

167

1164

1.45

4.92

1.1

5.85

5.57

u/ml

0.05

528

Heart failure, strict

132

1364

0.67

4.89

1.1

4.22

3.37

u/ml

0.17

610

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1242

5758

1.15

4.88

1.1

5.38

4.99

u/ml

0.23

623

2602

Other otitis externa (chronic)

421

1.75

4.87

1.1

14.65

5.17

u/ml

0.57

196

Menorrhagia

363

1573

1.29

4.85

1.1

4.31

4.92

u/ml

0.20

153

714

Persons encountering health services in other circumstances

475

3809

1.24

4.83

1.1

6.14

5.50

u/ml

0.26

207

1771

Disorders of skin appendages

626

5194

1.20

4.78

1.1

4.63

5.35

u/ml

0.54

293

2405

Umbilical hernia

235

1745

1.35

4.75

1.1

2.75

3.72

u/ml

0.75

115

768

Other disorders of patella

203

1474

1.39

4.74

1.1

2.85

4.37

u/ml

0.93

625

Alzheimer disease

299

0.31

4.73

1.0

1.1

0.16

1.01

u/ml

—

144

Type 1 diabetes

173

2414

0.71

4.72

1.1

5.05

5.65

u/ml

0.20

1151

Viral and other specified intestinal infections, including avohilmo

451

3509

1.24

4.71

1.1

4.53

6.92

u/ml

2.73

226

1727

Liquid cancers, including Hilmo

116

1539

0.66

4.69

1.1

2.43

4.41

u/ml

1.63

696

Other bacterial intestinal infections, including avohilmo

200

1451

1.38

4.68

1.1

3.16

5.10

u/ml

0.89

645

Recurrent aphthous stomatitis , including avohilmo

156

1086

1.45

4.65

1.1

2.98

6.02

u/ml

2.40

515

Hypertrophy of breast

207

1514

1.38

4.64

1.1

4.56

u/ml

0.00

641

Injury, poisoning and certain other consequences of external causes

663

2769

1.20

4.64

1.1

5.45

4.72

u/ml

0.39

309

1228

Dental pulpitis, including avohilmo

1153

6453

1.15

4.61

1.1

4.80

5.04

u/ml

0.16

528

2914

Sulfonylureas

564

0.48

4.59

1.0

1.1

3.46

2.05

u/ml

0.48

237

Tramadol

787

4016

1.18

4.58

1.1

3.00

4.27

u/ml

1.48

376

1779

All-cause Heart Failure

130

1329

0.68

4.57

1.1

2.73

3.24

u/ml

0.15

595

Hypothyreosis and Thyroxine purchase for inclusion criteria

973

5507

1.16

4.57

1.1

3.95

4.92

u/ml

0.67

399

2489

Idiopathic pulmonary fibrosis

122

2.39

4.56

1.1

1.04

2.31

u/ml

0.70

Other disorders of white blood cells

248

1.96

4.55

1.2

1.1

2.28

5.67

u/ml

1.22

111

Dementia

595

0.53

4.55

1.0

1.1

1.48

2.15

u/ml

0.26

270

Appendectomy

752

6089

1.18

4.55

1.0

1.1

4.22

4.51

u/ml

0.19

332

2703

Heart failure,strict

130

1332

0.68

4.55

1.1

4.28

3.63

u/ml

0.12

588

Malignant neoplasm of digestive organs

100

1181

0.65

4.54

1.0

1.1

2.95

3.39

u/ml

0.17

519

Other neurological diseases

357

3489

0.79

4.54

1.1

3.04

4.22

u/ml

0.92

175

1552

Genitourinary diseases

695

2923

1.20

4.54

1.1

6.37

5.92

u/ml

0.19

327

1478

Schizoaffective disorder

659

0.47

4.52

1.1

2.60

3.77

u/ml

0.44

298

Benign neoplasm: Liver

155

2.24

4.51

1.0

1.1

4.92

5.95

u/ml

0.12

Benign neoplasm: Liver/bile ducts

168

2.18

4.51

1.0

1.1

4.69

5.94

u/ml

0.16

Hypothyroidism, strict autoimmune

818

4584

1.17

4.50

1.1

4.46

4.89

u/ml

0.19

339

2071

Certain disorders involving the immune mechanism

174

1243

1.41

4.50

1.1

2.79

4.34

u/ml

1.01

555

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

257

1.94

4.49

1.1

5.93

7.06

u/ml

0.09

123

Certain infectious and parasitic diseases

1173

5143

1.14

4.43

1.1

4.89

5.23

u/ml

0.24

559

2335

Non-rheumatic valve diseases

175

1730

0.72

4.42

1.1

2.61

4.73

u/ml

2.01

773

Nonorganic sleeping disorders

290

2246

1.30

4.41

1.1

6.27

5.40

u/ml

0.31

133

1034

Diseases of male genital organs

452

1834

1.24

4.41

1.1

4.33

5.59

u/ml

0.69

214

963

Endometriosis

387

1788

1.26

4.40

1.1

2.66

5.61

u/ml

4.27

178

818

Panic disorder

236

1779

1.34

4.39

1.1

4.26

4.95

u/ml

0.33

121

813

Septicaemia

166

2102

0.72

4.35

1.1

4.99

5.02

u/ml

0.01

959

Dialysis, with operation codes

637

0.47

4.35

1.0

1.1

5.94

5.44

u/ml

0.05

311

Other intervertebral disc disorders

823

4200

1.17

4.34

1.1

4.34

4.24

u/ml

0.04

368

1853

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

570

4700

1.20

4.34

1.1

5.02

5.67

u/ml

0.38

272

2199

Iron deficiency

393

1.74

4.32

1.1

2.55

5.75

u/ml

1.49

172

Acute and transient psychotic disorders

936

0.56

4.31

1.1

7.47

3.62

u/ml

0.48

412

Other septicaemia, including avohilmo

141

1883

0.70

4.28

1.1

5.75

4.70

u/ml

0.25

857

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

660

0.48

4.26

1.0

1.1

2.78

3.10

u/ml

—

268

Rotator cuff syndrome

489

2762

1.22

4.25

1.1

1.87

3.63

u/ml

3.86

212

1152

Embedded and impacted teeth

513

3447

1.21

4.24

1.1

7.26

6.12

u/ml

0.40

269

1680

Disorders of sclera, cornea, iris and ciliary body

543

4526

1.20

4.24

1.1

5.38

4.70

u/ml

0.43

264

2050

Hypermobility syndrome

588

1.59

4.22

1.1

4.18

5.53

u/ml

0.32

250

Other spirochaetal diseases, including avohilmo

299

2338

1.28

4.21

1.1

3.80

4.87

u/ml

0.59

129

1038

Prurigo nodularis

2.78

4.20

1.0

1.1

3.82

0.94

u/ml

—

Postmenopausal bleeding

146

525

1.46

4.19

1.1

1.31

2.56

u/ml

1.44

211

Dysplasia of cervi uteri

306

1680

1.29

4.18

1.1

3.01

4.99

u/ml

1.69

121

758

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

622

3295

1.20

4.18

1.1

4.06

5.63

u/ml

1.75

304

1447

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

758

0.52

4.18

1.1

10.81

4.93

u/ml

0.94

353

Other spirochaetal diseases

293

2288

1.29

4.18

1.1

3.86

4.83

u/ml

0.50

125

1015

Disorders of choroid and retina

425

3645

0.81

4.16

1.1

2.99

3.82

u/ml

0.65

187

1597

Lateral epicondylitis

131

903

1.46

4.16

1.1

1.0

2.04

3.89

u/ml

1.28

373

Transplanted organ and tissue status

678

0.50

4.15

1.0

1.1

11.00

6.76

u/ml

0.33

336

L04AD Calcineurin inhibitors

873

0.56

4.14

1.0

1.1

14.37

6.01

u/ml

1.06

426

Hernia of abdominal wall

351

2805

1.26

4.13

1.1

3.34

3.81

u/ml

0.31

164

1247

Other disorders of penis

589

1.57

4.13

1.1

4.54

5.85

u/ml

0.32

324

Viral pneumonia

118

798

1.49

4.12

1.1

8.19

4.31

u/ml

0.81

374

Vulvovaginal ulceration/inflammation in other diseases

110

735

1.51

4.12

1.1

6.29

4.98

u/ml

0.23

329

Other symptoms and signs involving the digestive system and abdomen

146

1029

1.43

4.11

1.1

3.45

4.90

u/ml

0.45

457

Inhalation and ingestion of food causing obstruction of respiratory tract

3.28

4.10

1.4

1.1

5.72

8.28

u/ml

—

Chronic kidney disease

1070

0.61

4.09

1.1

7.29

4.28

u/ml

0.49

498

Chondropathies

171

1241

1.39

4.08

1.0

1.1

5.85

5.47

u/ml

0.08

546

Bacterial pneumonia (organism specified)

321

2298

1.27

4.07

1.1

4.10

5.01

u/ml

0.44

182

1014

Use of disulfiram, acamprosate or naltrexone

633

0.49

4.07

1.1

2.09

3.99

u/ml

0.73

268

Postviral fatigue syndrome

2.58

4.05

1.3

1.1

2.78

5.99

u/ml

—

Other disorders of eyelid

236

1694

1.32

4.05

1.1

3.55

3.25

u/ml

0.10

710

Diseases of oral cavity, salivary glands and jaws

468

1971

1.23

4.04

1.1

4.72

4.17

u/ml

0.26

216

824

Other and unspecified rosacea

593

1.56

4.04

1.1

3.70

3.54

u/ml

0.04

245

Benign neoplasm: Ascending colon

414

1.67

4.03

1.1

4.10

2.13

u/ml

0.48

171

Injuries to the neck

278

2170

1.29

4.02

1.1

7.21

5.40

u/ml

0.55

130

991

Nephropathy related operations

630

0.49

4.00

1.0

1.1

5.94

5.60

u/ml

0.03

304

Mycoses

259

2005

1.30

3.98

1.1

4.59

4.90

u/ml

0.08

111

901

Extrapyramidal and movement disorders

247

1901

1.30

3.95

1.1

4.15

3.62

u/ml

0.18

115

827

Coronary artery bypass grafting

376

0.43

3.93

1.0

1.08

1.98

u/ml

—

161

Lumbar disc prolapse

618

3873

1.18

3.93

1.1

3.83

4.07

u/ml

0.13

289

1703

Other septicaemia

138

1827

0.71

3.92

1.1

5.81

4.73

u/ml

0.26

829

Other disorders of bone

216

1636

1.33

3.92

1.0

1.1

5.15

5.02

u/ml

0.03

731

Deep bite

191

1246

1.36

3.91

1.1

12.26

8.44

u/ml

0.63

671

Alzheimer disease, including avohilmo

351

0.43

3.91

1.0

1.1

0.12

1.02

u/ml

—

164

Other abnormal products of conception

538

2952

1.20

3.90

1.1

4.24

4.55

u/ml

0.17

231

1238

Allergic contact dermatitis due to drugs in contact with skin

113

2.34

3.88

1.2

1.1

17.13

6.20

u/ml

1.06

Trigger finger

124

858

1.45

3.88

1.1

2.87

3.65

u/ml

0.22

352

Metabolic disorders

751

5223

0.86

3.87

1.1

2.56

4.81

u/ml

5.40

367

2334

Insulin, fast-acting

210

2755

0.76

3.86

1.1

5.37

5.23

u/ml

0.04

100

1295

Obesity

733

5947

1.16

3.84

1.1

5.04

4.69

u/ml

0.14

338

2624

Keratitis

353

2850

1.24

3.83

1.1

6.44

4.56

u/ml

1.21

174

1278

Heart failure and antihypertensive medication

857

0.65

3.82

1.1

5.33

4.00

u/ml

0.19

379

Falls/tendency to fall

1308

5836

1.12

3.81

1.1

5.19

5.06

u/ml

0.07

640

2628

Persons encountering health services in circumstances related to reproduction

732

4219

1.17

3.80

1.1

5.70

5.91

u/ml

0.09

339

1995

Nonsuppurative otitis media

373

2629

1.24

3.78

1.1

5.65

7.08

u/ml

0.69

202

1300

Insulin, fast-acting or short human

210

2746

0.76

3.77

1.1

5.37

5.26

u/ml

0.03

100

1294

Obesity and other hyperalimentation

733

5949

1.16

3.76

1.1

5.04

4.69

u/ml

0.14

338

2625

Zoster [herpes zoster], including avohilmo

389

3066

1.23

3.76

1.1

5.32

4.27

u/ml

0.46

175

1339

Herpesviral [herpes simplex] infections

120

832

1.45

3.74

1.1

8.64

4.12

u/ml

1.41

372

Fall on same level involving ice and snow

555

4689

1.19

3.74

1.1

6.19

4.70

u/ml

0.64

264

2114

Cervicobrachial syndrome

204

1543

1.33

3.74

1.1

6.39

4.00

u/ml

0.38

639

Implicit Sepsis

473

4173

0.83

3.73

1.1

4.34

4.79

u/ml

0.25

228

1893

Stomatitis and related lesions

218

1668

1.31

3.70

1.1

3.19

5.56

u/ml

2.17

103

771

Other obstetric conditions, not elsewhere classified

624

3352

1.18

3.70

1.1

4.24

5.57

u/ml

1.34

302

1468

Nausea and vomiting

247

1872

1.29

3.69

1.1

5.13

6.45

u/ml

0.48

133

907

Cervical polyps

511

1.58

3.68

1.0

1.1

5.08

3.18

u/ml

0.28

207

N06DA Anticholinesterases

368

0.44

3.65

1.0

1.1

0.07

1.14

u/ml

—

173

Use of anticholinesterases

368

0.44

3.65

1.0

1.1

0.07

1.14

u/ml

—

173

Olecranon bursitis

232

1.87

3.65

1.1

7.64

3.98

u/ml

0.78

Benign lipomatous neoplasm

214

1636

1.31

3.64

1.0

1.1

4.23

3.67

u/ml

0.15

101

718

Shoulder lesions

667

3419

1.17

3.63

1.1

2.26

3.99

u/ml

3.86

284

1479

Polyp of the female genital tract

269

1188

1.29

3.62

1.1

2.55

3.38

u/ml

0.41

116

524

Continuous positive airway pressure

169

1037

1.36

3.62

1.1

5.61

6.30

u/ml

0.16

487

Diseases of arteries, arterioles and capillaries

253

2364

0.78

3.61

1.1

2.48

3.28

u/ml

0.73

109

1034

Other complications of surgical and medical care, not elsewhere classified

634

1.51

3.60

1.2

1.1

3.43

4.20

u/ml

0.16

272

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

755

5863

0.87

3.60

1.1

5.39

4.99

u/ml

0.21

343

2690

Erysipelas

261

2849

0.79

3.59

1.0

1.1

4.70

3.46

u/ml

0.70

145

1228

Other viral diseases, not elsewhere classified

242

1882

1.29

3.57

1.1

9.68

6.59

u/ml

0.85

119

921

Lyme disease, including avohilmo

284

2258

1.26

3.57

1.1

3.89

4.57

u/ml

0.33

124

996

Lyme disease

284

2258

1.26

3.57

1.1

3.89

4.57

u/ml

0.33

124

996

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

115

799

1.45

3.56

1.0

1.1

1.90

3.57

u/ml

1.25

337

Type 1 diabetes, wide definition

162

2173

0.74

3.55

1.1

5.65

5.56

u/ml

0.02

1048

Other disorders starting during childhood or adolecense, excluding more controls

116

773

1.45

3.54

1.1

7.31

8.03

u/ml

0.13

425

Haemorrhoids and perianal venous thrombosis

239

1850

1.29

3.51

1.1

3.49

3.43

u/ml

0.02

818

Other functional intestinal disorders

411

3089

1.21

3.50

1.1

4.26

5.95

u/ml

1.16

191

1461

Oral lichen planus

2.40

3.50

1.0

1.1

4.46

3.13

u/ml

0.29

Complications of medical and surgical care

671

5200

1.16

3.49

1.1

3.93

4.39

u/ml

0.29

324

2260

Explicit Sepsis

210

2473

0.77

3.46

1.1

4.98

5.15

u/ml

0.05

110

1145

Type 1 diabetes, wide definition, subgroup 1

158

2118

0.74

3.46

1.1

5.27

5.55

u/ml

0.08

1022

Gluteal tendinitis

215

1.88

3.46

1.1

2.10

3.66

u/ml

0.47

Disorders of other endocrine glands

462

3813

1.20

3.45

1.1

4.78

5.97

u/ml

0.71

224

1808

Other viral hepatitis, including avohilmo

634

0.53

3.44

1.1

6.48

4.63

u/ml

0.21

286

Implicit Sepsis, including avohilmo

586

4887

0.85

3.44

1.1

4.37

4.88

u/ml

0.30

276

2227

All influenza

239

1870

1.28

3.43

1.1

3.10

5.91

u/ml

2.05

116

890

Pre-eclampsia or poor fetal growth

300

3693

0.80

3.43

1.1

4.37

4.65

u/ml

0.09

123

1600

Disorders of vestibular function (Vertigo)

325

2565

1.24

3.43

1.1

3.31

3.46

u/ml

0.07

149

1087

Bacterial infection, other or unspecified

245

2620

0.79

3.42

1.1

3.01

4.26

u/ml

0.80

113

1174

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

509

4223

1.18

3.41

1.1

4.12

3.98

u/ml

0.07

243

1845

Explicit Sepsis, including avohilmo

218

2538

0.78

3.41

1.1

4.87

5.08

u/ml

0.06

113

1170

Other/unspecified dorsalgia

342

2755

1.23

3.41

1.1

2.98

4.55

u/ml

1.78

163

1228

Abnormal findings in secretions and smears from cervix uteri vagina vulva

661

4196

1.16

3.39

1.0

1.1

3.62

4.54

u/ml

0.83

262

1809

Spirochaetal infections, other/unspecified, including avohilmo

285

2282

1.25

3.39

1.1

3.89

4.84

u/ml

0.49

124

1008

Pleural plaque

2.39

3.39

1.1

0.42

1.66

u/ml

—

Other arthrosis

416

2308

1.21

3.38

1.1

2.42

3.55

u/ml

1.37

194

944

Unspecified event, undetermined intent

189

1.94

3.37

1.1

6.10

6.20

u/ml

0.01

Substance use, excluding alcohol

136

1858

0.73

3.36

1.1

7.27

5.07

u/ml

0.73

843

Endometriosis ASRM stages 1,2

226

1764

1.29

3.36

1.1

2.69

4.71

u/ml

1.90

778

Colonic or urogenital fistula

228

1780

1.29

3.35

1.1

5.17

3.80

u/ml

0.38

784

Polyarthropathies

522

3945

0.85

3.35

1.1

2.72

4.88

u/ml

3.30

229

1751

Type 1 diabetes, strict (exclude DM2)

1265

0.67

3.35

1.1

6.23

6.82

u/ml

0.11

634

Melanocytic naevi of eyelid, including canthus

3.51

3.35

1.2

1.1

14.27

2.58

u/ml

—

Erosion of teeth , including avohilmo

353

2899

1.22

3.34

1.1

5.63

5.59

u/ml

0.01

171

1361

140

914

1.38

3.33

1.1

1.99

2.47

u/ml

0.21

392

COPD, hospital admissions 3, with asthma pneumonia sepsis

522

1.50

3.32

1.1

4.54

2.20

u/ml

0.57

229

Congenital malformations, deformations and chromosomal abnormalities

771

6398

1.14

3.32

1.1

5.47

5.40

u/ml

0.04

380

2943

Toxic effect of contact with venomous animals

285

1.74

3.30

1.1

4.58

5.82

u/ml

0.19

131

Persons encountering health services in other circumstances, wide

1249

5758

1.12

3.30

1.1

5.11

4.99

u/ml

0.07

601

2602

Atherosclerosis, excluding cerebral and coronary sclerosis

753

0.62

3.30

1.1

1.12

2.18

u/ml

1.33

330

malignant neoplasm of male genital organs

580

0.62

3.30

1.0

0.72

2.81

u/ml

3.03

263

Hernia of abdominal wall, postoperative

140

1014

1.38

3.30

1.1

2.26

3.45

u/ml

0.93

437

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

819

6274

0.88

3.30

1.1

4.31

4.91

u/ml

0.33

397

2838

Other and unspecified nerve root and plexus disorders, also in other diseases

189

1444

1.31

3.29

1.0

1.1

3.18

3.64

u/ml

0.17

622

Injury of muscle and tendon at lower leg level

129

930

1.39

3.28

1.1

3.46

3.60

u/ml

0.04

403

Single spontaneous delivery

300

1962

0.80

3.27

1.1

5.42

6.16

u/ml

0.28

150

909

Mental retardation, wide definition

525

0.50

3.26

1.2

1.1

3.14

9.91

u/ml

1.75

314

Uterine polyps

240

1096

1.28

3.25

1.1

1.84

3.11

u/ml

1.26

111

478

Disorders of orbit

242

1.80

3.24

1.1

1.46

3.56

u/ml

1.13

102

Persons with potential health hazards related to communicable diseases

575

4899

1.17

3.24

1.1

5.53

6.04

u/ml

0.27

284

2354

Disorders of refraction and accommodation

369

3042

1.21

3.23

1.1

6.28

6.42

u/ml

0.03

174

1440

Viral hepatitis, including avohilmo

685

0.56

3.23

1.1

6.30

4.55

u/ml

0.21

311

Unspecified/other endometriosis

142

1023

1.37

3.22

1.1

3.01

5.41

u/ml

1.62

468

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

303

1.71

3.21

1.1

4.78

6.11

u/ml

0.29

143

Bleeding

501

4127

0.85

3.21

1.1

4.83

4.70

u/ml

0.05

233

1883

Implicit viral Sepsis, including avohilmo

233

1831

1.27

3.20

1.1

5.57

5.48

u/ml

0.02

126

823

Other specified/unspecified soft tissue disorders

185

1.91

3.20

1.0

5.84

3.95

u/ml

0.18

Crushed, pushed or stepped on by crowd or human stampede

118

846

1.41

3.15

1.1

5.53

6.48

u/ml

0.16

409

Other abnormal uterine and vaginal bleeding

199

1100

1.30

3.15

1.1

1.85

5.02

u/ml

3.83

102

495

Bacterial Sepsis

183

1966

0.77

3.15

1.0

1.1

3.54

4.23

u/ml

0.29

890

Infections with a predominantly sexual mode of transmission

438

3685

1.19

3.15

1.1

5.36

5.12

u/ml

0.10

195

1679

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

362

0.41

3.14

1.2

1.1

14.01

4.63

u/ml

—

172

Implicit fungal Sepsis, including avohilmo

304

1.69

3.14

1.1

6.25

4.96

u/ml

0.17

132

Abrasion of teeth

331

2719

1.22

3.14

1.1

2.07

3.84

u/ml

3.07

158

1134

Benign neoplasm: Colon

278

2100

1.24

3.13

1.1

2.96

3.12

u/ml

0.07

121

880

Pneumonia due to other infectious organisms, not elsewhere classified

131

2.08

3.13

1.1

6.01

4.42

u/ml

0.14

Injury of muscle and tendon at hip and thigh level

680

1.45

3.12

1.1

5.33

4.95

u/ml

0.05

288

Benign neoplasm of other and ill-defined parts of digestive system

107

754

1.42

3.11

1.1

3.19

3.53

u/ml

0.11

311

Type 1 diabetes, definitions combined

1268

0.69

3.11

1.1

7.06

6.75

u/ml

0.05

633

Malignant neoplasm of skin, including Hilmo

216

1842

0.78

3.10

1.1

1.82

3.27

u/ml

1.80

777

Hypertensive diseases

682

4411

0.87

3.09

1.1

3.60

4.25

u/ml

0.50

304

1936

Diseases of inner ear

381

3037

1.20

3.08

1.1

3.07

3.78

u/ml

0.52

177

1298

Endometriosis of ovary

168

1200

1.32

3.08

1.1

2.20

4.25

u/ml

1.73

538

Viral infections characterized by skin and mucous membrane lesions

420

3532

1.19

3.08

1.1

5.87

5.46

u/ml

0.17

202

1670

Disorders of lipoprotein metabolism and other lipidaemias

509

3619

0.85

3.05

1.1

2.24

3.73

u/ml

2.65

255

1527

Chronic suppurative otitis media, including avohilmo

585

1.48

3.04

1.1

4.95

6.60

u/ml

0.45

292

Otitis media, unspecified

193

1378

1.30

3.04

1.2

1.1

11.44

8.57

u/ml

0.49

113

706

Fall on and from stairs and steps

229

1814

1.27

3.04

1.1

5.49

5.13

u/ml

0.10

119

824

Inflammatory disease of uterus

184

1420

1.30

3.03

1.2

1.1

4.44

4.95

u/ml

0.13

629

Presence of cardiac and vascular implants and grafts

101

1050

0.71

3.03

1.1

1.0

3.10

3.39

u/ml

0.05

480

Kidney transplant status

369

0.43

3.03

1.1

17.28

7.25

u/ml

—

187

Hypertension

682

4402

0.87

3.02

1.1

3.60

4.20

u/ml

0.45

304

1933

Mental retardation

510

0.52

3.01

1.2

1.1

3.14

9.96

u/ml

1.77

307

Dental operations

490

2135

1.18

3.01

1.1

4.02

4.45

u/ml

0.20

222

918

Chronic periodontitis, complicated

281

3359

0.81

3.00

1.0

1.1

2.98

3.54

u/ml

0.31

138

1429

Benign paroxysmal vertigo

192

1490

1.29

3.00

1.1

2.37

3.29

u/ml

0.55

630

Bacterial infection, other or unspecified, including avohilmo

309

3079

0.82

2.99

1.1

3.65

4.83

u/ml

0.83

146

1379

Malignant neoplasm of respiratory system and intrathoracic organs

441

0.53

2.99

1.0

1.1

0.69

3.24

u/ml

—

188

Examination and encounter for administrative purposes

301

1.67

2.98

1.1

1.0

6.59

5.48

u/ml

0.09

103

Ulcer of vagina/vulva

227

1.79

2.98

1.1

10.67

6.32

u/ml

0.32

102

Crowding of teeth, including avohilmo

199

1286

1.29

2.97

1.1

12.09

8.91

u/ml

0.62

129

681

Other viral hepatitis

591

0.55

2.97

1.1

6.48

4.36

u/ml

0.24

261

Postmenopausal atrophic vaginitis

154

624

1.35

2.96

1.0

1.1

3.44

2.91

u/ml

0.19

249

Malignant neoplasm of skin

193

1675

0.78

2.96

1.1

1.86

3.19

u/ml

1.42

704

Stenosis and insufficiency of lacrimal passages

443

1.54

2.95

1.1

4.44

3.91

u/ml

0.11

197

Alzheimer disease, excluding more controls

193

0.37

2.95

1.0

1.1

0.19

0.88

u/ml

—

Disorders of iron metabolism

2.36

2.94

1.1

7.98

4.28

u/ml

—

Patellar tendinitis

142

2.01

2.93

1.0

1.1

15.12

8.14

u/ml

0.44

Defects in the complement system

2.60

2.93

1.1

3.77

7.70

u/ml

—

Other and unspecified visual disturbances

606

1.46

2.93

1.2

1.1

2.89

3.56

u/ml

0.29

266

Pedestrian injured in collision with pedal cycle

177

1.89

2.93

1.0

1.1

2.63

5.26

u/ml

0.94

Malignant neoplasm of bronchus and lung

340

0.47

2.91

1.0

1.1

0.98

2.88

u/ml

—

142

Deficiency of other B group vitamins

2.40

2.91

1.1

0.66

4.68

u/ml

—

Carpal tunnel syndrome

530

3953

1.16

2.90

1.1

4.19

3.45

u/ml

0.24

215

1695

Mental and behavioural disorders due to use of other stimulants, including caffeine

333

0.41

2.90

1.1

11.30

5.46

u/ml

—

158

Oxycodone

135

1543

0.75

2.90

1.1

3.69

3.57

u/ml

0.02

674

Factors influencing health status and contact with health services

291

1182

1.24

2.90

1.1

1.0

5.53

5.32

u/ml

0.06

142

463

Other and unspecified disorders of vitreous body

233

1819

1.25

2.88

1.0

1.1

3.26

3.03

u/ml

0.07

724

Mental and behavioural disorders due to opioids

401

0.47

2.87

1.1

1.46

4.94

u/ml

3.40

189

Other congenital malformations of skin, including avohilmo

100

709

1.42

2.87

1.1

4.81

5.85

u/ml

0.30

332

Hypothyroidism, strict autoimmune, 3 medication purchases required

867

5177

1.13

2.87

1.1

4.22

4.85

u/ml

0.33

356

2314

Other disorders of male genital organs

237

1.75

2.86

1.0

1.1

1.34

4.69

u/ml

2.42

125

Anogenital herpesviral [herpes simplex] infection, including avohilmo

179

1389

1.30

2.86

1.1

4.66

5.56

u/ml

0.25

654

Lichen ruber planus, wide definition including periferal and oral lichen planus

154

1169

1.32

2.86

1.1

3.41

3.82

u/ml

0.09

488

Immunodeficiencies

329

1.63

2.85

1.1

1.82

7.33

u/ml

3.50

154

Viral hepatitis

634

0.58

2.84

1.1

6.48

4.44

u/ml

0.23

281

Other/unspecified synovitis and tenosynovitis

103

735

1.41

2.84

1.1

5.69

3.90

u/ml

0.33

309

Redundant prepuce, phimosis and paraphimosis

188

1444

1.29

2.83

1.1

5.95

5.68

u/ml

0.06

106

735

Epiphora

2.37

2.83

1.0

1.1

0.77

3.78

u/ml

—

Retinal breaks without detachment

100

710

1.41

2.83

1.1

1.96

3.64

u/ml

1.29

292

Benign neoplasm of eye and adnexa

464

1.52

2.82

1.0

1.1

1.59

4.31

u/ml

2.57

204

Benign neoplasm: Choroid

238

1.73

2.81

1.0

1.1

0.87

3.85

u/ml

1.78

101

Impacted teeth

392

2839

1.19

2.81

1.1

7.61

6.81

u/ml

0.27

208

1405

Hypertrophy of tongue papillae

2.51

2.81

1.1

1.0

2.44

4.24

u/ml

—

Other disorders of breast

146

1105

1.33

2.79

1.0

1.1

3.12

4.61

u/ml

0.54

484

Infections of the skin and subcutaneous tissue

643

5548

1.14

2.78

1.1

7.81

5.11

u/ml

1.69

328

2607

Other shoulder lesions

688

1.42

2.78

1.1

1.74

4.14

u/ml

1.92

298

Tracheo-bronchomalasia

3.37

2.77

1.3

1.0

2.36

7.63

u/ml

—

Nonalcoholic fatty liver disease

697

1.42

2.77

1.0

1.1

2.39

4.34

u/ml

0.82

297

Sequelae of cerebrovascular disease

1006

0.69

2.76

1.0

1.1

2.85

2.81

u/ml

0.01

433

Injury of muscle and tendon at shoulder and upper arm level

223

1783

1.25

2.76

1.1

2.56

3.60

u/ml

0.62

100

773

Other/unspecified disorders of vestibular function

159

1.90

2.76

1.1

3.69

4.56

u/ml

0.10

Disorders of thyroid, IBD co-morbidities

213

1154

1.27

2.74

1.1

5.44

4.52

u/ml

0.13

530

Budesonide

133

996

1.34

2.73

1.0

1.1

4.21

4.37

u/ml

0.03

407

Intestinal adhesions without obstruction

294

1.64

2.71

1.0

1.1

3.38

3.85

u/ml

0.07

137

Acute nasopharyngitis (common cold)

120

879

1.36

2.71

1.1

4.51

4.34

u/ml

0.05

391

Other enthesopathy of foot (+metatarsalgia)

701

1.41

2.69

1.1

4.03

3.91

u/ml

0.02

291

Complications predominantly related to the puerperium

333

2787

1.20

2.68

1.1

4.01

4.78

u/ml

0.34

148

1219

Myotonic disorders

2.86

2.67

1.2

1.1

2.26

4.71

u/ml

—

Type 1 diabetes, strict definition

1148

0.70

2.67

1.1

7.35

6.92

u/ml

0.07

579

Other disorders of cornea

511

1.48

2.67

1.1

9.52

4.64

u/ml

1.14

214

Exclusions for E4_PCOS_CONSORTIUM

744

5231

0.89

2.66

1.1

3.71

5.25

u/ml

1.52

296

2392

Type 1 diabetes, strict definition, subgroup 1

1101

0.69

2.66

1.1

6.64

6.92

u/ml

0.05

559

Post-traumatic stress disorder

147

1124

1.32

2.66

1.1

6.22

5.36

u/ml

0.09

521

malignant neoplasm of male genital organs, including Hilmo

613

0.67

2.66

1.0

1.1

1.03

2.73

u/ml

1.93

280

False labour

505

2704

1.16

2.65

1.1

4.14

5.74

u/ml

1.41

222

1175

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

328

1.60

2.64

1.0

1.1

2.27

4.54

u/ml

0.83

145

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.50

2.64

1.3

1.0

2.35

6.25

u/ml

—

Heart failure and coronary heart disease

827

0.70

2.63

1.1

4.31

3.15

u/ml

0.17

368

Chronic viral hepatitis

505

0.55

2.63

1.1

7.17

4.08

u/ml

0.34

231

Superficial injury of hip and thigh

106

771

1.38

2.62

1.1

6.07

4.44

u/ml

0.37

346

Other reaction to severe stress, and adjustment disorders

486

4199

1.16

2.62

1.1

6.77

4.75

u/ml

1.27

248

1865

Any operation in hilmo

183

1.60

2.62

1.1

7.74

7.26

u/ml

0.04

Melanocytic naevi

325

2720

1.20

2.61

1.1

5.04

4.86

u/ml

0.05

146

1227

Other acute skin changes due to ultraviolet radiation

134

1.96

2.61

1.1

1.51

3.67

u/ml

0.98

Subacute thyroiditis

229

1.72

2.61

1.0

1.1

2.94

5.69

u/ml

0.53

Later onset COPD

255

1.61

2.61

1.0

1.1

0.56

1.21

u/ml

1.08

120

Disorders of ocular muscles, binocular movement, accommodation and refraction

581

5046

1.14

2.59

1.1

5.75

5.66

u/ml

0.03

285

2347

Other diseases of stomach and duodenum

214

1.74

2.59

1.2

1.1

4.43

2.92

u/ml

0.17

Habitual aborter

238

1.71

2.58

1.0

1.1

2.39

4.07

u/ml

0.50

103

Rheumatism, unspecified

681

1.40

2.58

1.1

1.0

1.38

3.54

u/ml

1.99

269

Other sexually transmitted chlamydial diseases, including avohilmo

197

1571

1.26

2.58

1.1

7.59

7.02

u/ml

0.13

106

771

Sarcoidosis

101

732

1.39

2.58

1.1

3.15

3.18

u/ml

0.01

310

Other noninflammatory disorders of vagina

532

1.46

2.57

1.0

1.1

2.44

4.78

u/ml

0.77

228

Noninfectious colitis NAS

132

998

1.33

2.57

1.1

3.55

4.50

u/ml

0.39

461

Sciatica+with lumbago

477

3648

1.16

2.56

1.1

6.64

4.06

u/ml

1.03

221

1588

Malignant neoplasm of brain, including Hilmo

260

0.38

2.56

1.2

1.1

17.92

5.12

u/ml

—

126

Hypersensitivity pneumonitis due to organic dust

2.54

1.1

0.52

3.66

u/ml

—

Benign neoplasm of middle ear and respiratory system

300

1.61

2.53

1.1

2.42

5.22

u/ml

1.23

133

malignant neoplasm of female genital organs, including Hilmo

760

0.65

2.52

1.0

1.1

1.46

3.84

u/ml

2.64

319

Other disorders of conjunctiva

501

1.46

2.51

1.0

1.1

5.24

3.61

u/ml

0.32

200

Flat foot [pes planus] (acquired)

568

1.43

2.50

1.1

6.36

3.87

u/ml

0.40

235

Other diseases of anus and rectum

202

1612

1.25

2.50

1.1

5.00

4.00

u/ml

0.26

715

Heart failure and bmi 25plus

803

0.71

2.49

1.1

1.0

4.55

2.61

u/ml

0.34

344

Disorders of breast

539

4144

1.15

2.49

1.1

4.36

4.54

u/ml

0.09

227

1770

Procreative management

459

3264

1.16

2.49

1.1

4.84

6.48

u/ml

1.08

242

1560

Polyarteritis nodosa and related conditions

2.42

2.48

1.2

1.0

0.56

7.58

u/ml

—

Atypical facial pain

302

1.60

2.48

1.1

1.29

4.93

u/ml

1.99

131

Benign lipomatous neoplasm of other sites/unspecified

286

1.62

2.48

1.0

1.1

10.32

2.54

u/ml

0.78

125

Combinations of oral blood glucose lowering drugs

1184

0.72

2.47

1.1

1.0

3.88

2.79

u/ml

0.19

502

Impingement syndrome of shoulder

149

1153

1.30

2.46

1.1

1.0

2.51

3.62

u/ml

0.57

477

Major coronary heart disease event excluding revascularizations

203

1665

0.80

2.45

1.1

1.0

1.86

2.83

u/ml

0.88

731

Immunodeficiency with predominantly antibody defects

174

1.81

2.44

1.0

1.1

2.10

6.70

u/ml

1.78

Endometriosis of rectovaginal septum and vagina

464

1.48

2.44

1.1

1.26

3.87

u/ml

2.83

195

Other retinal disorders

294

2670

0.83

2.43

1.1

2.72

3.76

u/ml

0.85

128

1194

Disorders of muscles

664

1.39

2.43

1.1

2.89

4.48

u/ml

0.75

286

All influenza (not pneumonia)

148

1147

1.30

2.43

1.1

1.48

5.77

u/ml

6.03

538

Malignant neoplasm of bronchus and lung, including Hilmo

413

0.56

2.42

1.0

1.1

1.12

3.16

u/ml

1.36

170

Emotional disorders starting during childhood or adolecense, excluding more controls

102

728

1.37

2.41

1.1

7.06

8.12

u/ml

0.19

398

Status post-ami

424

0.59

2.41

1.0

0.44

2.28

u/ml

2.75

184

Other epidermal thickening

235

1.67

2.39

1.1

3.49

6.50

u/ml

0.69

107

Oter anti-inflammatory and antirheumatic agents, non-steroids

369

1.40

2.38

1.1

1.70

3.18

u/ml

0.88

176

Alzheimer’s disease, strict definition

238

0.44

2.37

1.0

1.1

0.16

1.00

u/ml

—

110

L04AA Selective immunosuppressants

137

1767

0.77

2.37

1.1

5.24

4.99

u/ml

0.05

790

Complications of procedures, not elsewhere classified

778

5614

1.12

2.37

1.1

3.47

4.54

u/ml

1.16

355

2476

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

319

2696

1.19

2.36

1.1

5.58

5.51

u/ml

0.02

143

1264

Pure hypercholesterolaemia

421

3098

0.86

2.35

1.1

2.49

3.64

u/ml

1.43

220

1298

Liquid cancers

100

1273

0.74

2.34

1.1

2.42

4.72

u/ml

1.69

571

Other and specified injuries of hip and thigh

2.11

2.34

1.2

1.1

0.75

6.25

u/ml

—

Other/unspecified enthesopathies of lower limb, excluding foot

510

1.44

2.33

1.0

1.1

2.80

4.58

u/ml

0.75

216

Complications associated with artificial fertilization

192

1.75

2.33

1.1

6.52

4.33

u/ml

0.35

Ventral hernia

151

1180

1.28

2.33

1.1

3.85

3.04

u/ml

0.35

498

Poor fetal growth

134

1725

0.77

2.32

1.1

3.11

5.00

u/ml

0.87

764

Hard cardiovascular diseases

567

3802

0.88

2.32

1.1

3.58

4.45

u/ml

0.62

230

1702

Other immunodeficiencies

2.17

2.32

1.1

3.18

6.63

u/ml

—

Atrial fibrillation and flutter

179

1445

0.80

2.32

1.1

1.66

3.87

u/ml

3.47

606

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

2.31

0.0

1.1

—

8.21

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

599

0.62

2.31

1.1

2.73

4.28

u/ml

0.51

252

Otitis externa, unspecified

120

912

1.32

2.30

1.1

4.97

5.17

u/ml

0.04

413

Benign neoplasm: Duodenum

2.39

2.30

1.2

1.1

4.51

2.39

u/ml

—

Pain associated with micturition

731

1.36

2.29

1.0

1.1

7.70

4.76

u/ml

0.63

338

Short Achilles tendon (acquired)

141

1.86

2.29

1.0

1.32

4.44

u/ml

1.11

Other predominantly sexually transmitted diseases, not elsewhere classified

242

2001

1.22

2.28

1.1

4.75

4.90

u/ml

0.05

108

926

Dislocation, sprain and strain of joint and ligaments of hip

141

1.86

2.28

1.1

11.57

5.51

u/ml

0.36

Parkinson's disease, including avohilmo

314

0.48

2.25

1.0

1.1

0.38

2.09

u/ml

—

139

Giant cell arteritis with polymyalgia rheumatica

0.00

2.25

0.0

1.1

—

5.09

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

137

1063

1.29

2.25

1.1

4.33

5.23

u/ml

0.32

503

Polyuria

131

1011

1.30

2.24

1.1

1.81

3.62

u/ml

1.98

450

Generalized skin eruption due to drugs and medicaments

240

1.64

2.23

1.0

1.1

6.08

6.68

u/ml

0.07

105

Exposure to other and unspecified inanimate mechanical forces

650

1.38

2.23

1.1

3.27

4.54

u/ml

0.66

314

Monoamine oxidase A inhibitors

590

1.40

2.23

1.1

3.30

2.78

u/ml

0.14

253

Hypothyroidism (congenital or acquired)

419

2024

1.16

2.22

1.1

5.47

5.18

u/ml

0.07

177

946

Gingivitis and periodontal diseases

1005

4716

1.10

2.22

1.1

5.09

4.76

u/ml

0.19

480

2102

Mental retardation, excluding more controls

437

0.57

2.22

1.2

1.1

3.33

9.29

u/ml

1.34

252

Benign neoplasm of bone and articular cartilage

600

1.39

2.21

1.0

1.1

3.28

4.75

u/ml

0.53

263

LeFortI or BSSO operation

393

1.49

2.21

1.1

1.42

5.52

u/ml

3.69

176

Fracture of femur

719

0.68

2.20

1.0

1.1

2.32

4.15

u/ml

0.67

342

Congenital malformations of the respiratory system

158

1.80

2.20

1.2

1.1

0.93

11.14

u/ml

4.59

Panniculitis affecting regions of neck and back

195

1.71

2.20

1.1

2.31

4.11

u/ml

0.56

Concussion

595

4092

1.13

2.19

1.1

4.44

5.64

u/ml

0.95

293

1938

Unspecified fall

460

3946

1.15

2.19

1.1

5.96

5.94

u/ml

0.00

239

1864

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

158

1.79

2.18

1.1

3.61

4.24

u/ml

0.10

Haemangioma and lymphangioma, any site

610

1.39

2.18

1.1

5.78

4.82

u/ml

0.15

284

Bruxism

166

1.78

2.18

1.1

1.91

4.38

u/ml

—

Thyroiditis, ILD-related definition

124

955

1.31

2.18

1.1

7.18

4.55

u/ml

0.18

412

MS-disease / Multiple Sclerosis

673

0.65

2.18

1.0

1.1

2.35

3.56

u/ml

0.46

300

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

526

0.64

2.17

1.0

1.1

0.86

3.59

u/ml

2.63

229

Open wound of wrist and hand

481

4078

1.14

2.16

1.1

5.28

4.97

u/ml

0.14

218

1897

Bacterial pneumonia, not elsewhere classified

277

2043

1.19

2.16

1.1

3.76

4.77

u/ml

0.54

162

906

Melanoma in situ

115

1.92

2.16

1.0

1.1

1.37

4.56

u/ml

—

Sequelae of injuries, of poisoning and of other consequences of external causes

211

1732

1.22

2.15

1.1

3.51

4.01

u/ml

0.28

101

760

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

212

1.67

2.15

1.1

5.61

4.62

u/ml

0.14

Bacterial pneumoniae

299

2221

1.18

2.15

1.1

4.16

4.83

u/ml

0.29

174

999

Pleural plaque with presence of asbestos

2.30

2.14

1.1

0.68

1.50

u/ml

—

Oral lichen planus, including avohilmo , including avohilmo

330

1.52

2.14

1.1

2.26

3.57

u/ml

0.51

138

malignant neoplasm of female genital organs

645

0.65

2.14

1.0

1.1

1.62

3.87

u/ml

1.92

261

Cardiomyopathy (excluding other)

475

0.59

2.14

1.1

11.87

4.87

u/ml

0.40

214

Metatarsalgia

638

1.37

2.13

1.1

4.24

3.67

u/ml

0.10

261

Other local infections of skin and subcutaneous tissue

664

1.36

2.12

1.0

1.1

8.03

4.31

u/ml

0.96

301

Other and unspecified polyneuropathies, also in other diseases

672

1.36

2.12

1.1

5.43

3.91

u/ml

0.27

287

Thyroiditis

487

1.43

2.12

1.1

12.32

4.53

u/ml

0.34

214

Contraceptive management

511

3144

1.14

2.12

1.1

5.70

4.98

u/ml

0.33

223

1394

Pediculosis, acariasis and other infestations, including avohilmo

237

1972

1.21

2.12

1.1

7.38

6.48

u/ml

0.21

120

946

Other maternal disorders predominantly related to pregnancy

711

3990

1.12

2.12

1.1

5.02

4.99

u/ml

0.01

304

1733

Delivery

320

1979

0.85

2.11

1.1

5.74

6.21

u/ml

0.15

157

919

Pneumonia due to Streptococcus pneumoniae

213

1.66

2.10

1.0

1.1

6.35

4.33

u/ml

0.18

Asymmetry of jaw

146

1.82

2.10

1.1

3.67

7.86

u/ml

0.80

Use of biperiden

264

0.45

2.10

1.0

1.1

14.95

2.88

u/ml

—

119

Inflammatory disorders of breast

658

1.36

2.10

1.0

1.1

5.37

4.31

u/ml

0.30

290

Separation of retinal layers (serosa)

221

1.64

2.10

1.1

2.26

3.90

u/ml

0.66

Other/unspecified soft tissue disorders related to use, overuse and pressure

183

1.71

2.09

1.1

1.0

2.40

5.74

u/ml

0.97

Persistent delusional disorders

408

0.56

2.09

1.1

7.17

3.26

u/ml

0.60

178

Haemorrhage in early pregnancy

349

2918

1.17

2.09

1.1

3.49

4.65

u/ml

1.06

143

1252

Skin changes due to chronic exposure to nonionizing radiation

111

765

1.31

2.08

1.1

2.20

2.49

u/ml

0.09

332

Meniscus derangement

441

2552

1.15

2.08

1.1

2.74

3.74

u/ml

0.75

199

1060

Temporal arteritis

0.00

2.06

0.0

1.1

—

5.58

—

Juvenile osteochondrosis

334

1.52

2.06

1.0

1.1

5.56

6.82

u/ml

0.14

156

Viral conjunctivitis, including avohilmo

342

1.51

2.06

1.1

6.11

5.78

u/ml

0.04

156

Viral pneumonia (unknown virus, not influenza)

432

1.44

2.05

1.1

10.51

4.34

u/ml

0.84

200

Myocardial infarction

145

1276

0.79

2.05

1.1

1.82

2.68

u/ml

0.53

550

Prolapse and hernia of ovary and fallopian tube

3.48

2.03

1.0

1.1

—

0.94

—

Actinic keratosis

102

701

1.32

2.03

1.1

2.37

2.54

u/ml

0.05

308

Parkinson's disease

301

0.50

2.02

1.0

1.1

0.38

2.13

u/ml

—

134

Female infertility, tubal origin

384

1.47

2.02

1.1

0.81

4.05

u/ml

3.83

158

Foreign body in alimentary tract

327

1.51

2.02

1.1

3.20

6.29

u/ml

1.05

162

Coronary atherosclerosis

253

1898

0.84

2.01

1.1

2.72

3.04

u/ml

0.16

106

812

Hypothyroidism, levothyroxine purchases

413

2013

1.15

2.01

1.1

5.54

5.11

u/ml

0.11

175

938

Hypothyroidism and >3 levothyroxin purchases

413

2013

1.15

2.01

1.1

5.54

5.11

u/ml

0.11

175

938

Mental and behavioural disorders due to cannabinoids

363

0.54

2.00

1.1

9.29

5.61

u/ml

0.36

172

Other and unspecified injuries of lower leg

663

1.35

2.00

1.1

9.97

5.23

u/ml

0.33

311

Non-selective monoamine reuptake inhibitors

240

1929

1.20

1.98

1.1

3.76

3.01

u/ml

0.27

123

795

Hypertensive diseases (excluding secondary)

549

3589

0.89

1.98

1.1

3.89

4.52

u/ml

0.39

250

1611

Deep bite that required surgery

1.98

1.0

1.1

2.16

5.56

u/ml

—

Hallux rigidus

519

1.39

1.97

1.1

3.74

3.58

u/ml

0.04

214

Other deformities of toe(s)

141

1.79

1.97

1.0

1.1

0.53

4.09

u/ml

2.19

Impacted cerumen

494

1.40

1.97

1.1

9.60

5.51

u/ml

0.67

246

Other diseases of gallbladder

156

1.74

1.96

1.1

0.30

3.18

u/ml

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

149

1191

1.25

1.96

1.1

4.47

5.14

u/ml

0.24

555

Disorders of lacrimal system and orbit in diseases classified elsewhere

134

1.81

1.96

1.0

1.1

0.42

4.18

u/ml

1.96

Hyperplasia of prostate

156

699

1.26

1.96

1.1

1.0

0.75

2.89

u/ml

4.48

328

Contracture of joint

2.39

1.96

1.0

4.77

4.48

u/ml

—

Convergence insufficiency and excess

120

1.87

1.95

1.2

1.1

4.20

8.36

u/ml

0.69

Use of pramipexole

123

962

1.28

1.95

1.1

3.23

3.09

u/ml

0.05

406

Exophthalmic conditions

2.48

1.94

1.0

1.14

6.66

u/ml

—

Spontaneous abortion

550

3277

1.13

1.94

1.1

3.70

4.52

u/ml

0.62

230

1393

Other specified/unspecified bacterial intestinal infections

306

1.51

1.93

1.1

3.44

5.05

u/ml

0.36

140

Urethritis and urethral syndrome

113

1.88

1.93

1.2

1.1

1.06

4.18

u/ml

—

conjunctival haemorrhage

242

1.58

1.92

1.0

1.1

8.27

3.64

u/ml

0.50

103

Acute epiglottitis

2.08

1.92

1.1

0.78

3.35

u/ml

—

Medicines for HER+ breast cancer

175

1989

0.82

1.92

1.1

2.35

3.39

u/ml

0.84

802

Chronic suppurative otitis media

455

1.42

1.92

1.1

5.45

7.35

u/ml

0.39

218

Scabies, including avohilmo

215

1793

1.20

1.92

1.1

7.09

6.53

u/ml

0.11

105

871

Other sexually transmitted chlamydial diseases

118

923

1.29

1.91

1.1

7.62

6.08

u/ml

0.32

433

Lichen planus, including avohilmo

122

956

1.28

1.91

1.0

1.1

4.17

3.61

u/ml

0.10

399

Other disorders starting during childhood or adolescence

119

923

1.29

1.91

1.1

8.00

9.75

u/ml

0.33

525

Exclusions for E4_PCOS_BROAD

189

1556

1.22

1.90

1.1

3.89

6.12

u/ml

0.91

760

Other sleep disorders

738

1.32

1.90

1.1

4.05

4.89

u/ml

0.25

324

Acute lymphadenitis

524

1.38

1.90

1.1

4.81

5.31

u/ml

0.10

244

Other disorders of Eustachian tube

181

1.67

1.89

1.1

1.12

5.16

u/ml

2.37

Cardiomyopathies, Primary/intrinsic

446

0.60

1.89

1.1

11.87

5.11

u/ml

0.38

204

Neuromuscular dysfunction of bladder

406

1.43

1.89

1.1

3.89

3.09

u/ml

0.15

181

Other symptoms and signs involving the nervous and musculoskeletal systems

382

3338

1.15

1.89

1.1

5.76

5.02

u/ml

0.19

184

1528

Peroneal tendinitis

114

1.87

1.89

1.0

1.1

7.73

6.02

u/ml

—

Other endocrine disorders

651

1.34

1.88

1.1

10.06

9.33

u/ml

0.10

378

Implicit bacterial Sepsis

145

1544

0.80

1.88

1.0

1.1

3.60

3.91

u/ml

0.10

682

Myocardial infarction, strict

130

1159

0.79

1.87

1.1

1.13

2.58

u/ml

2.33

506

Viral meningitis, including avohilmo

317

1.50

1.87

1.1

3.63

5.81

u/ml

0.79

146

485

0.62

1.87

1.2

1.1

5.36

11.26

u/ml

1.62

307

Care involving use of rehabilitation procedures

588

4743

1.12

1.87

1.1

4.77

4.88

u/ml

0.03

301

2106

Lichen planus

542

1.37

1.86

1.1

5.69

2.85

u/ml

0.48

232

Bicipital tendinitis

205

1.62

1.86

1.1

1.37

5.14

u/ml

1.61

Perforation of tympanic membrane

637

1.34

1.86

1.1

5.40

5.77

u/ml

0.07

288

Other specified/unspecified arthritis

230

1935

1.19

1.86

1.0

1.1

2.63

4.80

u/ml

2.08

103

842

Hypertensive heart and/or renal disease

563

0.70

1.86

1.1

1.53

2.99

u/ml

0.94

242

Benign neoplasm of colon, rectum, anus and anal canal

343

2513

1.15

1.85

1.1

3.30

3.00

u/ml

0.14

148

1062

Other female pelvic inflammatory diseases

137

1094

1.26

1.85

1.1

1.99

3.85

u/ml

1.51

466

Coxarthrosis [arthrosis of hip](FG)

242

1969

0.84

1.84

1.1

2.05

3.12

u/ml

0.87

814

Urticaria due to cold and heat

2.17

1.84

1.1

1.0

7.95

9.39

u/ml

—

Peripheral artery operations in Hilmo

290

0.52

1.84

1.2

1.1

1.18

2.33

u/ml

—

129

Other erythematous conditions

175

1.67

1.83

1.1

1.78

6.39

u/ml

1.59

Haemangioma, any site

553

1.36

1.83

1.1

5.55

5.13

u/ml

0.06

261

Other superficial mycoses, including avohilmo

138

1107

1.25

1.81

1.1

4.40

5.70

u/ml

0.41

508

Spirochaetal infections, other/unspecified

435

1.41

1.81

1.0

1.1

3.11

5.27

u/ml

0.51

196

Acute otitis externa, noninfective

2.02

1.81

1.2

1.0

3.37

8.60

u/ml

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

168

1.68

1.81

1.0

1.1

3.41

4.92

u/ml

0.35

542

0.65

1.81

1.1

6.73

10.93

u/ml

0.92

340

Other gastritis (incl. Duodenitis)

121

955

1.27

1.80

1.1

2.06

3.57

u/ml

1.18

403

Other bacterial intestinal infections

117

920

1.28

1.80

1.1

3.56

4.00

u/ml

0.09

413

Care involving dialysis

377

0.58

1.80

1.0

1.1

7.93

5.75

u/ml

0.17

184

Hypertension, essential

655

4094

0.90

1.79

1.1

3.16

3.75

u/ml

0.52

295

1747

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

120

931

1.27

1.78

1.1

8.12

8.50

u/ml

0.06

510

Sequelae of other external causes

312

1.48

1.78

1.2

1.1

2.38

5.03

u/ml

1.05

138

Suppurative otitis media, unspecified

200

1.62

1.78

1.0

1.1

14.42

6.44

u/ml

0.58

Need for other prophylactic measures

370

1.44

1.78

1.1

2.12

4.95

u/ml

1.36

185

Mixed conductive and sensorineural hearing loss

428

1.41

1.78

1.1

1.68

3.79

u/ml

1.64

193

ILD medications: immunosuppressive drugs

591

4819

1.11

1.77

1.0

1.1

5.24

5.17

u/ml

0.03

268

2063

Other mycoses, not elsewhere classified/unspecified, including avohilmo

102

1.89

1.77

1.0

1.1

4.43

5.75

u/ml

—

Chronic ulcer of skin, not elsewhere classified

233

0.47

1.77

1.2

1.1

0.60

4.19

u/ml

—

101

Contact with and exposure to communicable diseases

488

4335

1.12

1.77

1.1

6.19

6.17

u/ml

0.01

227

2088

Disorder of the sleep-wake schedule

162

1.69

1.77

1.1

4.83

6.63

u/ml

0.26

L02BG Aromatase inhibitors

113

1412

0.79

1.76

1.1

2.48

3.41

u/ml

0.49

571

Event of undetermined intent

557

1.36

1.76

1.1

7.53

5.61

u/ml

0.25

259

Severe mental retardation

0.00

1.76

0.0

1.1

—

8.11

—

Inflammation of lacrimal passages (acute and unspecified)

2.05

1.76

1.2

1.1

0.22

4.52

u/ml

—

Transient ischemic attack

163

1581

0.82

1.76

1.0

1.1

1.76

3.14

u/ml

1.65

671

Sequelae of injuries of upper limb

652

1.33

1.76

1.1

2.91

4.53

u/ml

0.77

294

Obsessive-compulsive disorder

117

925

1.27

1.76

1.1

5.65

6.37

u/ml

0.13

441

Other diseases of intestine

617

1.33

1.75

1.0

1.1

3.21

3.03

u/ml

0.04

272

Bacterial intestinal infections, IBD co-morbidities

116

915

1.27

1.75

1.1

3.73

3.93

u/ml

0.04

411

Superficial injury of thorax

121

960

1.26

1.75

1.1

5.58

4.43

u/ml

0.29

425

Reactive arthropathies

549

1.35

1.75

1.1

5.04

4.04

u/ml

0.19

231

Demyelinating diseases of the central nervous system

768

0.71

1.74

1.0

1.1

2.44

3.57

u/ml

0.54

342

Cholecystectomy

559

4264

1.11

1.74

1.1

3.71

3.61

u/ml

0.05

235

1818

Crossbite

133

984

1.25

1.73

1.1

8.83

8.47

u/ml

0.06

555

Other congenital malformations of skin

356

1.45

1.73

1.1

6.97

7.61

u/ml

0.10

185

Testicular dysfunction

274

1.51

1.72

1.0

1.1

3.35

3.82

u/ml

0.09

134

Whooping cough, including avohilmo

179

1.65

1.72

1.2

1.1

6.12

8.45

u/ml

0.24

Leukaemia of unspecified cell type

0.00

1.72

0.0

1.0

—

4.18

—

Infectious mononucleosis, including avohilmo

144

1170

1.24

1.72

1.1

4.97

7.12

u/ml

0.81

570

Infectious mononucleosis

144

1170

1.24

1.72

1.1

4.97

7.12

u/ml

0.81

570

Malignant neoplasm of bone and articular cartilage

0.00

1.71

0.0

1.0

—

6.36

—

Malignant neoplasm of prostate

471

0.71

1.71

1.0

1.1

0.75

2.74

u/ml

2.30

203

Reimbursement for rheumatic diseases

392

4406

0.88

1.71

1.0

1.1

2.45

4.71

u/ml

3.64

172

1974

Disorders of oesophagus in diseases classified elsewhere

2.31

1.71

1.3

1.1

0.33

6.00

u/ml

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

115

1000

0.79

1.70

1.1

2.52

4.01

u/ml

0.86

419

Atrial septal defect

416

0.61

1.70

1.1

4.28

9.91

u/ml

1.34

245

Other and unspecified local infections of skin and subcutaneous tissue

638

1.32

1.70

1.0

1.1

8.31

4.40

u/ml

0.95

288

Benign neoplasm of other and unspecified endocrine glands

690

1.31

1.70

1.0

1.1

2.32

4.02

u/ml

1.09

300

Antihypertensive medication - note that there are other indications

980

4718

1.09

1.70

1.1

6.10

5.94

u/ml

0.06

461

2251

Radiculopathy

699

1.31

1.69

1.2

1.1

3.24

3.67

u/ml

0.10

288

Type1 diabetes, definitions combined, early onset

976

0.75

1.69

1.1

5.59

7.42

u/ml

0.46

499

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

727

5035

0.91

1.69

1.1

2.36

4.15

u/ml

4.74

325

2198

Sacrococcygeal disorders, not elsewhere classified

203

1.59

1.69

1.2

1.1

1.72

4.62

u/ml

1.70

Glaucoma suspect

179

1486

1.21

1.69

1.1

2.91

3.21

u/ml

0.10

646

Premenstrual syndrome

157

1.68

1.0

1.1

0.94

5.68

u/ml

2.46

Aplastic and other anaemias

171

1884

0.83

1.68

1.1

5.36

4.24

u/ml

0.36

858

Other and unspecified acute skin changes due to ultraviolet radiation

2.20

1.68

1.0

1.1

2.26

2.29

u/ml

—

Benign neoplasm: Skin of eyelid, including canthus

657

1.31

1.67

1.1

7.08

3.52

u/ml

0.65

278

Parkinson's disease, excluding more controls

258

0.53

1.67

1.0

0.38

2.40

u/ml

—

115

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

2.13

1.67

1.5

1.0

1.22

6.31

u/ml

—

severe traumatic brain injury, does not include concussion

843

0.73

1.66

1.1

4.84

4.09

u/ml

0.19

382

Other puerperal infections

130

1049

1.25

1.66

1.1

7.77

4.17

u/ml

0.94

472

Symptoms and signs involving the nervous and musculoskeletal systems

500

4485

1.12

1.65

1.1

5.74

5.08

u/ml

0.20

242

2078

Congenital malformations of the respiratory system, including avohilmo

181

1.63

1.65

1.2

1.1

0.93

10.38

u/ml

4.75

100

Sequelae of infectious and parasitic diseases, including avohilmo

418

1.39

1.65

1.1

11.09

3.39

u/ml

0.81

174

Acute generalized exanthematous pustulosis

277

1.49

1.64

1.0

1.1

5.93

6.84

u/ml

0.12

126

General examination and investigation of persons without complaint and reported diagnosis

621

2914

1.11

1.64

1.1

5.80

5.54

u/ml

0.09

303

1227

Other systemic involvement of connective tissue

189

1584

1.20

1.63

1.1

2.84

4.69

u/ml

1.10

684

Retained placenta and membranes, without haemorrhage

118

943

1.26

1.63

1.1

2.40

3.98

u/ml

0.77

397

Other systemic involvement of connective tissue (FG)

189

1555

1.20

1.63

1.1

2.84

4.55

u/ml

0.99

671

Cellulitis

199

1677

1.19

1.63

1.1

6.84

4.60

u/ml

0.71

767

Diabetic nephropathy, excluding more controls

476

0.68

1.62

1.2

1.1

4.22

4.02

u/ml

0.02

229

Maternal care for other known or suspected fetal problems

334

2388

0.87

1.62

1.1

4.75

5.87

u/ml

0.54

148

1052

Disorders of vitreous body

280

2305

1.16

1.62

1.0

1.1

3.20

3.08

u/ml

0.04

114

958

Secondary uncertain malignant neoplasm

451

0.64

1.61

1.1

3.02

4.82

u/ml

0.50

190

Benign intracranial hypertension

121

1.77

1.61

1.1

3.35

7.30

u/ml

—

Other specified/unspecified spondylopathies

2.16

1.61

1.0

1.1

0.67

2.75

u/ml

—

Premature rupture of membranes

355

2221

1.14

1.61

1.1

4.05

5.39

u/ml

0.70

141

991

Suicide or other Intentional self-harm

199

2351

0.84

1.61

1.1

7.34

5.57

u/ml

0.50

104

1075

Emotional disorders and disorders of social functioning with onset specific to childhood

114

892

1.26

1.60

1.1

6.72

9.12

u/ml

0.56

488

Sequelae of infectious and parasitic diseases

412

1.39

1.60

1.1

11.50

3.42

u/ml

0.82

172

Struck by thrown, projected or falling objec

421

1.39

1.60

1.2

1.1

7.65

5.34

u/ml

0.29

201

Autoimmune diseases

1126

6141

0.93

1.60

1.1

4.90

5.43

u/ml

0.35

519

2880

Hypertensive Heart Disease

487

0.70

1.59

1.0

1.1

1.47

3.14

u/ml

0.89

213

Keratoconus

167

1.63

1.59

1.1

14.36

3.67

u/ml

1.21

Mental and behavioural disorders due to sedatives or hypnotics

556

0.68

1.59

1.1

5.35

4.47

u/ml

0.15

248

Myopia

173

1444

1.20

1.59

1.1

6.22

5.74

u/ml

0.10

663

Periapical abscess

338

3838

0.88

1.59

1.1

5.26

4.67

u/ml

0.26

180

1712

Cluster headache, wide,, including avohilmo

456

1.37

1.58

1.1

3.10

4.45

u/ml

0.59

196

Benign neoplasm: Skin of ear and external auricular canal

121

1.75

1.58

1.0

1.1

3.07

6.25

u/ml

—

Helminthiases

1.84

1.58

1.2

1.1

8.82

6.99

u/ml

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

556

0.68

1.58

1.1

5.08

3.80

u/ml

0.13

252

Ménière disease

354

1.42

1.58

1.1

3.74

3.39

u/ml

0.05

151

Other demyelinating diseases of the central nervous system

349

0.60

1.58

1.0

1.1

3.56

4.10

u/ml

0.11

149

Other noninflammatory disorders of vulva and perineum

770

1.28

1.57

1.1

6.57

5.85

u/ml

0.10

345

Polyneuropathies and other disorders of the peripheral nervous system

109

867

1.26

1.57

1.1

5.05

3.87

u/ml

0.25

382

Graves ophthalmopathy

137

1.70

1.56

1.0

1.1

0.42

3.44

u/ml

1.96

Collagenous colitis

517

1.34

1.56

1.1

3.20

5.06

u/ml

0.65

230

Disorders of vitreous body and globe

286

2353

1.15

1.55

1.0

1.1

3.29

3.07

u/ml

0.08

118

981

Car occupant injured in other and unspecified transport accidents

214

1825

1.18

1.54

1.1

5.68

5.21

u/ml

0.13

842

Other benign neoplasms of uterus

122

1.73

1.54

1.0

1.1

3.59

2.68

u/ml

—

Diseases of tongue

281

1.47

1.54

1.1

2.93

3.45

u/ml

0.09

104

Achilles tendinitis

605

1.31

1.54

1.1

4.81

3.84

u/ml

0.17

254

Hypertrophic disorders of skin

519

1.34

1.54

1.1

7.05

5.21

u/ml

0.27

235

Alcoholic liver disease

372

0.62

1.53

1.0

1.1

7.99

3.19

u/ml

0.35

164

Maternal care for other conditions predominantly related to pregnancy

321

2751

1.14

1.53

1.1

2.88

4.96

u/ml

1.59

146

1197

Parkinson's disease, strict definition

259

0.54

1.53

1.0

1.1

0.30

1.51

u/ml

—

122

Cardiac arrest

198

0.51

1.53

1.0

1.1

1.72

5.79

u/ml

—

Anoxic brain damage

0.00

1.53

0.0

1.0

—

4.67

—

Acute alcohol intoxication

147

1774

0.83

1.52

1.0

1.1

6.78

5.15

u/ml

0.47

785

Diabetes insipidus

0.00

1.52

0.0

1.1

—

7.23

—

Traumatic subdural haemorrhage

324

0.60

1.51

1.1

3.38

3.13

u/ml

—

157

Intentional self-harm by jumping from a high place

0.00

1.51

0.0

1.1

—

6.03

—

Excessive vomiting in pregnancy

110

882

1.25

1.51

1.1

5.49

5.57

u/ml

0.01

387

Peripheral arterial reconstruction

296

0.57

1.51

1.2

1.1

2.67

1.83

u/ml

—

126

Testicular hypofunction

242

1.50

1.0

1.1

3.07

3.77

u/ml

0.13

120

Dilated cardiomyopathy

382

0.63

1.50

1.1

12.95

3.85

u/ml

0.50

177

Erythema nodosum

162

1.62

1.50

1.0

1.1

0.79

6.85

u/ml

2.68

Other heart diseases

518

3720

0.90

1.49

1.1

4.17

5.25

u/ml

0.75

242

1719

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

284

1.46

1.48

1.1

7.67

6.39

u/ml

0.12

126

Other hearing loss

118

924

1.24

1.48

1.1

5.43

3.36

u/ml

0.48

411

Localized swelling, mass and lump of skin and subcutaneous tissue

264

2297

1.15

1.47

1.1

4.60

4.81

u/ml

0.07

103

1044

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

147

1766

0.83

1.47

1.1

8.01

5.70

u/ml

0.54

807

Synovial cyst of popliteal space [Baker]

284

1.45

1.47

1.1

1.0

2.97

3.76

u/ml

0.12

123

Infections of genitourinary tract in pregnancy

880

0.76

1.47

1.1

2.29

4.88

u/ml

1.79

395

Extracorporeal dialysis

255

0.55

1.47

1.1

7.03

4.85

u/ml

—

115

Non-ischemic cardiomyopathy

808

0.77

1.47

1.1

3.23

3.36

u/ml

0.02

367

Maternal care related to the fetus and amniotic cavity and possible delivery problems

599

3195

1.10

1.46

1.1

4.87

5.35

u/ml

0.26

259

1393

Other disorders of veins

312

2702

1.14

1.46

1.1

2.44

3.53

u/ml

0.86

132

1132

Complications of labour and delivery

695

3535

1.09

1.46

1.1

4.85

5.25

u/ml

0.21

306

1543

Mild mental retardation

253

0.55

1.45

1.3

1.1

6.42

8.55

u/ml

—

142

Lymphoid leukaemia

202

0.49

1.45

1.3

1.1

5.05

6.16

u/ml

—

108

Benign neoplasm: Rectum, anus and anal canal

672

1.28

1.45

1.1

3.41

2.92

u/ml

0.09

296

Heterophoria

744

1.27

1.45

1.1

5.01

6.82

u/ml

0.52

370

Poisoning by medicine

191

2239

0.85

1.44

1.1

9.82

5.53

u/ml

1.23

101

1024

Artrosis, including avohilmo

780

3931

1.09

1.44

1.1

3.71

u/ml

0.00

336

1744

Cluster headache, strict, including avohilmo

447

1.35

1.44

1.1

3.10

4.53

u/ml

0.63

192

Dermatitis herpetiformis

1.99

1.44

1.0

1.1

14.32

6.13

u/ml

—

Other specified disorders of external ear

125

1.69

1.44

1.0

1.1

3.51

2.98

u/ml

—

Anogenital herpesviral [herpes simplex] infection

719

1.27

1.43

1.1

3.67

4.73

u/ml

0.32

326

Disorders of gallbladder, biliary tract and pancreas

762

5139

0.92

1.43

1.1

3.36

4.11

u/ml

0.65

320

2254

Raynaud syndrome

692

1.28

1.43

1.0

1.1

2.66

3.81

u/ml

0.68

292

KRA_PSY_EATING, excluding more controls

145

1194

1.21

1.43

1.1

6.68

5.93

u/ml

0.13

563

Tongue abnormality

253

1.47

1.43

1.1

0.29

4.30

u/ml

3.30

109

Viral warts

104

835

1.25

1.42

1.1

5.50

5.78

u/ml

0.06

387

Mumps

141

1.65

1.42

1.0

1.1

3.67

2.78

u/ml

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

103

1.77

1.42

1.1

19.39

7.65

u/ml

—

Fracture at wrist and hand level

350

3101

1.13

1.42

1.1

7.48

5.03

u/ml

0.85

179

1452

Cluster headache, wide

287

1.44

1.41

1.0

1.1

3.42

4.08

u/ml

0.16

122

Presence of other devices

111

883

1.24

1.41

1.1

1.77

3.26

u/ml

0.99

384

Coeliac disease

112

908

1.24

1.41

1.1

7.21

5.51

u/ml

0.34

414

Obesity due to excess calories

523

4756

1.10

1.40

1.1

5.85

4.56

u/ml

0.46

235

2119

Other skin changes

123

1007

1.22

1.40

1.1

5.76

4.06

u/ml

0.37

450

Spondylosis

353

2450

1.13

1.40

1.0

1.1

3.64

3.49

u/ml

0.05

136

1027

Benign neoplasm: Other and unspecified parts of mouth

134

1.65

1.39

1.0

1.1

5.78

3.90

u/ml

—

Obstructed labour due to maternal pelvic abnormality

115

936

1.23

1.39

1.0

1.1

2.71

3.21

u/ml

0.17

374

Female genital prolapse

207

982

1.17

1.39

1.1

3.32

3.09

u/ml

0.11

425

Rash and other nonspecific skin eruption

589

1.30

1.39

1.1

6.46

4.94

u/ml

0.27

281

Viral meningitis

297

1.43

1.38

1.0

1.1

3.87

5.53

u/ml

0.54

136

Other peripheral vertigo

364

1.38

1.0

1.1

2.46

2.93

u/ml

0.19

157

Acute alcohol intoxication, ICD10

130

1569

0.83

1.38

1.0

1.1

7.09

5.32

u/ml

0.47

702

Other bursopathies

607

1.29

1.38

1.1

1.0

3.15

3.76

u/ml

0.14

254

Non-small cell lung cancer, including Hilmo

293

0.61

1.37

1.0

1.1

1.49

2.66

u/ml

—

122

Muscle strain

231

1.48

1.37

1.1

3.64

4.88

u/ml

0.22

108

Other abnormal auditory perceptions

1.86

1.37

1.3

1.0

6.62

4.58

u/ml

—

Superficial injury of wrist and hand

254

2220

1.15

1.36

1.1

7.31

6.19

u/ml

0.26

120

1072

Primary_lymphoid and hematopoietic malignant neoplasms

960

0.78

1.36

1.1

2.14

4.77

u/ml

1.62

445

Infections, IBD-co-morbidities

142

828

1.21

1.36

1.0

1.1

3.31

4.94

u/ml

0.52

391

Covid-19 suspected case

259

2267

1.15

1.36

1.1

5.61

5.38

u/ml

0.07

134

1044

Osteopathies and chondropathies

442

3645

1.11

1.36

1.1

4.42

4.80

u/ml

0.17

200

1645

Seropositive rheumatoid arthritis, strict definition

779

0.76

1.36

1.1

0.52

3.40

u/ml

6.90

322

Eustachian salpingitis and obstruction

108

877

1.24

1.36

1.1

3.35

4.84

u/ml

0.56

392

Implicit bacterial Sepsis, including avohilmo

181

1764

0.85

1.35

1.1

3.66

3.95

u/ml

0.10

779

Use of other anti-dementia drugs

241

0.60

1.35

1.1

3.19

1.10

u/ml

—

121

Use of memantine

241

0.60

1.35

1.1

3.19

1.10

u/ml

—

121

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

260

0.57

1.35

1.0

1.1

1.70

5.21

u/ml

—

103

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

405

3603

1.11

1.34

1.1

5.91

5.98

u/ml

0.02

219

1702

Other and unspecified disorders of skin and subcutaneous tissue

307

1.41

1.34

1.2

1.1

3.73

4.29

u/ml

0.08

134

Postdysenteric arthropathy

2.07

1.34

1.2

1.0

3.76

4.06

u/ml

—

Benign neoplasm: Scapula and long bones of upper limb

2.00

1.34

1.0

1.1

1.19

4.40

u/ml

—

Benign neoplasm: Short bones of lower limb

2.07

1.34

1.1

2.51

7.68

u/ml

—

Other injuries of lower limb, level unspecified

2.07

1.34

1.1

1.02

6.05

u/ml

—

Ulcer of lower limb, not elsewhere classified

442

0.68

1.34

1.1

1.10

4.03

u/ml

2.15

199

Other appendicitis

540

1.30

1.33

1.1

3.73

4.04

u/ml

0.05

240

Other arrhythmias

618

4231

1.09

1.33

1.1

3.52

4.48

u/ml

0.82

288

1860

Sacroiliitis, not elsewhere classified

454

1.33

1.32

1.0

1.1

2.33

4.45

u/ml

1.19

205

Parkinson's disease, strict definition, excluding more controls

230

0.57

1.32

1.0

1.1

0.30

1.58

u/ml

—

106

Acute pancreatitis

989

0.79

1.32

1.1

1.55

4.01

u/ml

2.92

428

Cerebral cysts

463

1.33

1.31

1.2

1.1

3.76

5.74

u/ml

0.58

211

Glaucoma-related operations

113

1.69

1.31

1.1

0.73

2.40

u/ml

—

Seborrhoeic keratosis

122

1006

1.21

1.31

1.1

1.53

2.75

u/ml

1.15

410

Other infective otitis externa

368

1.37

1.31

1.0

1.1

7.72

5.51

u/ml

0.23

166

Thoracic aortic aneurysm

454

1.32

1.31

1.1

2.10

3.10

u/ml

0.54

209

Acute pancreatitis (for exclusion)

987

0.79

1.30

1.1

1.55

3.86

u/ml

2.64

430

Residual foreign body in soft tissue

360

1.37

1.30

1.0

1.1

2.44

5.19

u/ml

1.15

164

Chalazion

773

1.25

1.30

1.1

3.91

4.88

u/ml

0.26

341

Benign neoplasms

1146

5851

1.07

1.30

1.1

4.90

5.28

u/ml

0.26

522

2732

Influenza and pneumonia

1185

6869

1.06

1.30

1.1

4.27

5.37

u/ml

1.42

616

3105

Procedures for purposes other than remedying health state

145

1.60

1.30

1.2

1.0

0.86

5.54

u/ml

—

Poisoning by drugs, medicaments and biological substances

214

2462

0.87

1.30

1.1

9.87

5.37

u/ml

1.47

113

1130

Sudden idiopathic hearing loss

429

1.33

1.29

1.1

6.27

4.38

u/ml

0.27

196

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

395

1.35

1.29

1.1

11.88

3.59

u/ml

0.81

161

Helminthiases, including avohilmo

430

1.34

1.29

1.1

12.93

6.24

u/ml

0.79

211

Exposure to other specified electric current

218

0.54

1.29

1.0

1.1

0.58

5.98

u/ml

—

106

Other and unspecified erythematous conditions

161

1.56

1.29

1.1

2.01

6.15

u/ml

1.22

Malignant neoplasm of prostate, including Hilmo

499

0.77

1.29

1.0

1.1

0.72

2.87

u/ml

2.74

217

Malignant neoplasm of breast, ER-negative, including Hilmo

1036

0.80

1.29

1.0

1.1

2.50

3.14

u/ml

0.21

416

Other diseases of liver

140

1173

1.20

1.29

1.1

2.26

4.37

u/ml

1.46

513

Other diseases of pleura

200

1497

1.16

1.29

1.1

2.89

4.01

u/ml

0.57

676

Disorders of mineral metabolism

421

1.34

1.28

1.1

3.16

5.20

u/ml

0.39

192

Medial epicondylitis

218

1.48

1.28

1.2

1.1

2.01

4.35

u/ml

0.67

Entropion and trichiasis of eyelid

145

1.59

1.28

1.0

2.14

2.45

u/ml

0.09

Measles

1.81

1.28

1.1

8.75

3.41

u/ml

—

Measles, including avohilmo

1.81

1.28

1.1

8.75

3.41

u/ml

—

Exposure to other and unspecified animate mechanical forces

319

1.39

1.28

1.1

3.04

5.66

u/ml

0.96

158

Abnormal blood-pressure reading, without diagnosis

243

1.45

1.28

1.0

1.1

2.43

3.95

u/ml

0.48

111

Other diseases of peritoneum

194

1.50

1.27

1.0

1.1

1.24

2.78

u/ml

0.98

Astigmatism

606

1.28

1.27

1.1

4.58

8.67

u/ml

1.68

328

Impetigo

519

1.30

1.27

1.2

1.1

12.03

5.79

u/ml

1.40

271

Respiratory insufficiency

114

1.66

1.26

1.1

1.0

1.88

3.69

u/ml

—

Mumps, including avohilmo

146

1.59

1.26

1.0

1.1

3.67

2.72

u/ml

—

Malignant neoplasm of breast, HER-negative

922

0.79

1.26

1.0

1.1

3.07

3.12

u/ml

0.01

373

Hypertrophic scar

484

1.31

1.26

1.1

8.14

5.43

u/ml

0.37

219

Benign neoplasm: Adrenal gland

294

1.40

1.26

1.0

1.1

1.27

2.20

u/ml

0.60

123

Fibroblastic disorders

120

993

1.21

1.26

1.1

1.0

2.78

3.69

u/ml

0.33

413

Other acquired deformities of musculoskeletal system and connective tissue

244

1.44

1.26

1.1

7.55

4.19

u/ml

0.25

103

Tooth eruption problems

265

2259

1.14

1.25

1.1

8.86

7.37

u/ml

0.31

150

1144

Lung diseases due to external agents

414

1.33

1.25

1.1

1.34

4.31

u/ml

2.50

186

Postpartum haemorrhage due to anatomy

166

1419

1.18

1.24

1.1

4.87

4.39

u/ml

0.13

627

Disorders of eyelid in diseases classified elsewhere

179

1.52

1.24

1.2

1.1

12.45

4.01

u/ml

0.81

Finngen Rheumatological endpoints

982

5945

0.94

1.23

1.1

3.43

5.33

u/ml

3.57

443

2685

Pterygium

1.91

1.23

1.1

1.06

2.68

u/ml

—

Ventricular septal defect, a heart condition

347

0.65

1.22

1.0

1.1

3.09

10.30

u/ml

4.85

212

Seropositive rheumatoid arthritis

109

1312

0.82

1.22

1.0

1.1

0.97

3.47

u/ml

5.80

548

Infections of breast associated with childbirth

417

1.33

1.22

1.1

1.74

4.85

u/ml

2.27

174

Other congenital malformations of the digestive system, including avohilmo

562

1.28

1.22

1.1

8.46

8.90

u/ml

0.05

321

Other keratitis

109

898

1.22

1.1

6.54

4.13

u/ml

0.71

388

Early lumbar disc prolapse, operated

131

1099

1.20

1.22

1.1

5.08

4.00

u/ml

0.23

470

Glomerular diseases

1021

0.80

1.21

1.0

1.1

1.79

4.60

u/ml

3.51

473

Postpartum care and examination

198

1432

0.86

1.21

1.1

6.08

6.98

u/ml

0.23

618

Insulin, fast-acting (human)

107

1295

0.82

1.21

1.1

4.70

4.51

u/ml

0.05

598

Other and unspecified corneal deformities and disorders

180

1.51

1.21

1.1

11.50

3.45

u/ml

1.14

Embedded teeth, including avohilmo

143

1210

1.19

1.21

1.1

8.76

6.78

u/ml

0.24

592

Cluster headache, strict

280

1.40

1.21

1.1

3.42

4.23

u/ml

0.20

117

Atrial fibrillation and flutter with reimbursement

113

861

0.83

1.21

1.1

0.62

3.45

u/ml

6.20

359

Systemic connective tissue disorders

237

2082

1.14

1.21

1.1

2.64

4.90

u/ml

1.85

109

911

Benign neoplasm: Caecum

305

1.38

1.21

1.1

3.42

2.00

u/ml

0.28

132

Long labour

344

2618

1.12

1.21

1.1

4.20

5.05

u/ml

0.36

156

1122

Nontraumatic intracranial haemmorrhage

605

0.74

1.20

1.0

1.1

4.45

3.24

u/ml

0.19

269

Contusion of toe(s) with damage to nail

1.77

1.20

1.1

1.0

22.11

5.78

u/ml

—

Inguinal hernia, bilateral

331

1.36

1.20

1.0

1.1

4.74

5.56

u/ml

0.10

148

Valvular operations

501

0.72

1.20

1.1

2.25

6.38

u/ml

2.12

237

Diverticular disease of intestine

452

2556

1.10

1.20

1.0

1.1

2.24

3.11

u/ml

0.81

190

1077

Congenital mitral valve regurgitation

0.00

1.20

0.0

1.1

—

14.60

—

Bilateral sagittal split ramus osteotomy operation

332

1.37

1.20

1.1

1.46

5.18

u/ml

2.88

149

Short stature, not elsewhere classified

446

1.31

1.19

1.1

1.2

9.78

10.99

u/ml

0.16

286

Caries of dentine, including avohilmo

732

3469

1.08

1.19

1.1

5.19

4.66

u/ml

0.29

365

1523

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

222

1.45

1.18

1.0

1.1

10.07

4.27

u/ml

0.58

Sequelae of other and unspecified infectious and parasitic diseases

393

1.33

1.18

1.1

12.35

3.61

u/ml

0.82

160

Basal cell carcinoma

154

1231

0.85

1.18

1.1

1.36

3.35

u/ml

2.57

518

Focal epilepsy

130

1539

0.84

1.17

1.1

5.22

5.51

u/ml

0.05

736

Delivery, wide proxy

281

1678

0.89

1.17

1.1

6.41

6.75

u/ml

0.09

140

781

Exposure to ignition of highly flammable material

2.54

1.16

1.0

1.1

7.86

2.21

u/ml

—

Malignant neoplasm of ovary, including Hilmo

248

0.60

1.16

1.0

1.1

0.75

4.47

u/ml

—

101

Varicose veins of other sites

351

1.34

1.15

1.0

1.1

4.10

3.85

u/ml

0.05

164

Basal cell carcinoma, including Hilmo

168

1322

0.86

1.15

1.1

1.59

3.26

u/ml

1.99

554

Other specified/unspecified hearing loss

325

1.36

1.15

1.1

6.44

3.75

u/ml

0.29

149

Abnormal findings on diagnostic imaging of central nervous system

334

1.35

1.15

1.0

1.1

7.71

6.13

u/ml

0.12

151

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

181

1411

0.86

1.15

1.1

1.98

3.14

u/ml

1.03

589

Other specified/unspecified disorders of bone/cartilage

134

1.58

1.15

1.1

6.20

5.80

u/ml

—

Lesion of plantar nerve

249

1.41

1.14

1.1

1.19

3.26

u/ml

1.41

105

Inguinal or femoral hernia, bilateral

334

1.35

1.14

1.0

1.1

4.74

5.52

u/ml

0.09

149

Angina pectoris

198

1507

0.87

1.14

1.1

1.0

1.82

2.81

u/ml

0.85

647

Impacted maxillary canine

119

1.63

1.14

1.1

13.93

11.69

u/ml

0.13

Vitamin deficiency

275

1.39

1.13

1.0

1.1

4.60

5.47

u/ml

0.09

124

Vitamin deficiency, wide

275

1.39

1.13

1.0

1.1

4.60

5.47

u/ml

0.09

124

Other/unspecified reactive arthropathies

422

1.31

1.13

1.1

4.08

5.12

u/ml

0.19

187

Bulimia nervosa (incl. atypical)

458

1.30

1.13

1.1

1.43

6.50

u/ml

4.49

209

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

446

3076

0.91

1.13

1.1

2.36

4.23

u/ml

3.36

195

1320

Fever of other and unknown origin

540

4308

1.09

1.12

1.1

3.88

5.15

u/ml

1.06

265

2008

Diplopia

698

1.24

1.12

1.1

4.37

4.48

u/ml

0.02

304

Pericarditis

151

1.53

1.12

1.1

1.25

5.64

u/ml

1.57

Viral pneumonia (known virus, not influenza)

135

1.57

1.12

1.1

3.14

7.16

u/ml

0.67

Pre-eclampsia or eclampsia

182

2089

0.87

1.11

1.1

4.98

4.19

u/ml

0.18

915

Use of antiglaucoma preparations and miotics

151

1.53

1.11

1.0

1.1

2.24

2.37

u/ml

0.03

Vascular disorders of the intestines

127

1.58

1.11

1.2

1.1

1.74

1.84

u/ml

—

Foreign body entering into or through eye or natural orifice

592

1.26

1.11

1.1

3.22

6.02

u/ml

1.49

286

Obesity, other/unspecified

368

3339

1.10

1.1

3.10

4.38

u/ml

1.12

178

1479

Speech and linguistic disorders, excluding more controls

133

1059

1.18

1.10

1.1

8.23

7.75

u/ml

0.09

573

Dyshidrosis [pompholyx]

112

1.62

1.10

1.0

1.1

2.54

3.94

u/ml

—

Sicca syndrome [Sjögren]

433

1.30

1.09

1.1

1.42

3.98

u/ml

2.05

176

Other/unspecified enthesopathies, not elsewhere classified

398

1.31

1.09

1.2

1.1

5.57

3.95

u/ml

0.14

174

Presbyopia

504

1.27

1.09

1.1

3.28

2.89

u/ml

0.10

199

Ischaemic heart disease, wide definition

378

2562

0.91

1.09

1.1

2.80

3.38

u/ml

0.37

151

1088

Hordeolum and other deep inflammation of eyelid

469

1.29

1.09

1.2

1.1

9.65

5.46

u/ml

0.58

223

Intestinal malabsorption

286

1.37

1.09

1.1

4.42

4.96

u/ml

0.10

135

Varicose veins

307

2577

0.90

1.09

1.0

1.1

2.11

3.20

u/ml

1.09

117

1050

Acne

189

1643

1.15

1.08

1.1

4.65

7.61

u/ml

1.83

832

Viral hepatitis, IBD co-morbidity

456

0.72

1.08

1.1

6.83

4.00

u/ml

0.33

219

Certain conditions originating in the perinatal period

169

1300

1.16

1.08

1.1

13.79

8.85

u/ml

0.88

718

Chronic apical periodontitis

1076

6384

0.94

1.08

1.1

4.15

4.99

u/ml

0.93

505

2857

Cauda equina syndrome

1.88

1.08

1.1

1.13

5.75

u/ml

—

Pulmonary embolism

138

1177

1.17

1.07

1.1

5.42

3.48

u/ml

0.37

501

Open wound of lower leg

125

1059

1.18

1.07

1.1

5.08

5.74

u/ml

0.18

494

Caught, crushed, jammed or pinched in or between objects

453

1.29

1.07

1.1

9.47

5.32

u/ml

0.96

213

Pulmonary heart disease

138

1178

1.17

1.07

1.1

5.42

3.47

u/ml

0.38

502

Polyarthrosis

705

1.21

1.06

1.0

1.1

3.75

3.36

u/ml

0.06

277

Primary hyperparathyroidism

391

1.31

1.06

1.0

1.1

0.65

3.17

u/ml

2.94

174

Viral infections of the central nervous system, including avohilmo

551

1.26

1.06

1.1

4.30

4.61

u/ml

0.08

248

Corneal ulcer

170

1477

1.15

1.06

1.1

6.50

4.05

u/ml

1.01

655

Glomerulonephritis

568

0.75

1.06

1.0

1.1

1.33

5.29

u/ml

3.81

271

Divergent concomitant strabismus

579

0.76

1.06

1.0

1.1

3.11

4.51

u/ml

0.33

257

Excessive earwax

468

3897

1.09

1.05

1.1

5.54

4.93

u/ml

0.26

219

1803

Abnormal findings on diagnostic imaging of breast

1.81

1.05

1.2

1.1

0.20

2.54

u/ml

—

Benign neoplasm: Rectum

587

1.25

1.05

1.1

3.59

3.14

u/ml

0.07

265

Tooth agenesis EXCLUDE clefts and syndromes

606

1.25

1.05

1.1

7.11

8.51

u/ml

0.24

322

Other disorders of prostate

1.80

1.04

1.1

0.15

1.75

u/ml

—

Reactive arthropathies, FINNGEN

490

1.27

1.04

1.1

4.25

u/ml

0.00

211

Radial styloid tenosynovitis [de Quervain]

437

1.29

1.04

1.1

5.79

3.31

u/ml

0.49

182

Scleritis and episcleritis

437

1.29

1.04

1.1

6.74

3.81

u/ml

0.46

182

Other protozoal intestinal diseases, including avohilmo

179

1.47

1.04

1.0

1.1

7.17

6.86

u/ml

0.03

Other congenital malformations, including avohilmo

164

1424

1.16

1.03

1.1

4.04

6.82

u/ml

1.79

709

Arthropathic psoriasis

723

0.79

1.03

1.1

1.68

4.09

u/ml

1.52

303

Other inflammation of vagina/vulva

385

1.31

1.03

1.0

3.84

4.89

u/ml

0.16

161

Melanocytic naevi of other and unspecified parts of face

411

1.30

1.03

1.1

4.42

5.15

u/ml

0.10

185

Emotional disorders starting during childhood or adolescence

104

863

1.20

1.03

1.1

6.97

10.20

u/ml

0.77

472

Alcohol-induced chronic pancreatitis

288

0.66

1.03

1.1

1.0

1.59

2.92

u/ml

0.74

121

Sexual dysfunction

114

1.59

1.03

1.1

6.27

2.47

u/ml

—

Atrial septal defect, secundum type

333

0.68

1.03

1.1

5.34

10.28

u/ml

0.93

200

Bullous disorders

204

1.43

1.03

1.0

1.1

18.59

5.46

u/ml

0.98

Hereditary corneal dystrophies

106

1.61

1.03

1.3

1.1

3.06

5.71

u/ml

0.52

Other hammer toe(s) (acquired)

502

1.25

1.03

1.1

2.65

2.94

u/ml

0.09

208

Scleritis

1.71

1.02

1.0

5.28

7.55

u/ml

—

Burn and corrosion of wrist and hand

342

1.32

1.02

1.1

16.95

6.68

u/ml

1.07

171

Colitis, primary sclerosing

107

0.46

1.02

1.0

1.1

—

8.10

—

Viral Sepsis

137

1175

1.17

1.02

1.1

6.67

5.75

u/ml

0.22

540

Injuries to the thorax

320

2896

1.11

1.01

1.1

4.64

4.54

u/ml

0.04

144

1313

Congenital malformations of cardiac septa

772

0.80

1.01

1.1

7.78

9.18

u/ml

0.25

428

Other complications of labour and delivery, not elsewhere classified

171

1731

0.87

1.01

1.1

7.04

5.63

u/ml

0.31

773

Autonomic disorders

147

1.51

1.01

1.0

1.1

2.35

5.84

u/ml

0.94

Monoplegia

1.78

1.01

1.0

1.1

0.32

5.82

u/ml

—

Trigeminal neuralgia

325

1.33

1.01

1.1

0.75

3.95

u/ml

3.02

138

Postpartum hemorraghe, parous women as controls

363

2767

1.10

1.00

1.1

4.43

4.13

u/ml

0.12

141

1193

Other misadventures during surgical and medical care

1.63

1.00

1.2

1.1

0.22

4.59

u/ml

—

Use of levodopa decarboxylase inhibitor

250

0.64

1.00

1.0

1.1

0.25

2.44

u/ml

—

115

Injuries to the hip and thigh

317

2573

1.11

1.00

1.1

4.78

4.96

u/ml

0.06

155

1182

Other malignant neoplasms of skin (=non-melanoma skin cancer)

168

1307

0.87

1.00

1.1

1.92

3.32

u/ml

1.28

546

Dizziness and giddiness

644

4670

1.07

0.99

1.1

3.81

4.61

u/ml

0.37

301

2072

Anomalies of pupillary function

156

1.49

0.99

1.2

1.1

4.86

8.41

u/ml

—

Foreign body in respiratory tract

361

1.31

0.99

1.1

3.53

6.24

u/ml

0.72

178

Other/unspecified seropositive rheumatoid arthritis

107

1266

0.84

0.99

1.0

1.1

0.99

3.46

u/ml

5.19

528

Rheumatic fever incl heart disease

1.72

0.99

1.0

1.1

3.38

4.51

u/ml

—

Seropositive rheumatoid arthritis, wide

109

1287

0.85

0.99

1.0

1.1

0.97

3.46

u/ml

5.43

535

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

106

1254

0.84

0.98

1.0

1.1

0.99

3.50

u/ml

5.27

522

Ischemic heart diseases

544

3490

0.93

0.98

1.1

3.25

4.35

u/ml

0.88

216

1551

Amblyopia ex anopsia

406

1.29

0.98

1.1

12.91

9.57

u/ml

0.16

219

Nerve, nerve root and plexus disorders

1006

5711

1.06

0.98

1.1

4.14

4.27

u/ml

0.06

421

2542

Injury of eye and orbit

145

1255

1.16

0.97

1.1

4.74

5.83

u/ml

0.29

578

Venous complications and haemorrhoids in pregnancy

223

0.62

0.97

1.1

3.53

5.37

u/ml

—

Implicit viral Sepsis

136

1171

1.16

0.97

1.1

6.10

5.78

u/ml

0.07

537

Burn and corrosion confined to eye and adnexa

165

1.47

0.97

1.1

1.35

4.89

u/ml

1.55

5-aminosalicylic acid

193

1704

1.13

0.97

1.1

6.52

5.55

u/ml

0.24

726

Other eating disorders

712

1.21

0.97

1.1

7.02

9.17

u/ml

0.29

363

Problems related to lifestyle

936

0.82

0.97

1.1

5.43

5.49

u/ml

0.01

421

Other abnormal findings of blood chemistry

267

1.35

0.96

1.0

1.1

3.29

6.42

u/ml

1.12

124

Fracture of shoulder and upper arm

218

2441

0.89

0.96

1.1

7.14

6.15

u/ml

0.23

103

1166

Focal epilepsy, mode (most common among epilepsy diagnosis)

110

1293

0.85

0.96

1.1

5.84

5.38

u/ml

0.07

619

Primary open-angle glaucoma

667

1.21

0.96

1.0

1.1

3.79

2.32

u/ml

0.24

299

Cardiac murmurs and other cardiac sounds

822

1.19

0.96

1.1

7.73

6.97

u/ml

0.13

397

Endocrine, nutritional and metabolic diseases

1062

5078

1.06

0.96

1.1

5.96

5.62

u/ml

0.16

494

2368

Benign neoplasm: Transverse colon

319

1.32

0.96

1.1

0.51

2.17

u/ml

2.20

143

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

234

0.63

0.96

1.0

1.1

9.59

5.89

u/ml

—

Benign neoplasm: Parotid gland

302

1.33

0.95

1.1

0.86

4.08

u/ml

2.49

127

Malignant neoplasm of other and unspecified female genital organs

0.00

0.95

0.0

1.0

—

1.47

—

Leiomyoma of uterus

502

3040

0.92

0.95

1.1

2.93

3.38

u/ml

0.30

189

1267

Dialysis

222

0.63

0.95

1.1

7.00

6.48

u/ml

—

113

Supervision of high-risk pregnancy

260

1737

0.90

0.95

1.1

4.94

6.22

u/ml

0.46

107

732

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

109

1.58

0.95

1.2

1.1

10.31

12.19

u/ml

0.11

Presbycusis

139

1.49

0.95

1.0

1.1

0.71

1.06

u/ml

0.29

Nontoxic goitre/thyroid nodule

163

1426

1.14

0.95

1.0

1.1

3.94

3.16

u/ml

0.18

608

Calcific tendinitis of shoulder

320

1.32

0.94

1.0

1.1

1.36

2.83

u/ml

0.85

124

Drug-induced cataract

125

1.53

0.94

1.1

11.86

6.19

u/ml

—

Neuralgia and neuritis, unspecified

294

1.33

0.94

1.1

2.92

4.04

u/ml

0.25

125

Iridocyclitis in diseases classified elsewhere

1.63

0.94

1.0

1.1

1.80

7.75

u/ml

—

Pyogenic arthritis

294

1.33

0.94

1.1

1.72

4.97

u/ml

1.77

135

Xanthelasma of eyelid

2.24

0.94

1.2

1.1

—

1.38

—

Open bite

753

1.20

0.93

1.1

5.57

8.17

u/ml

0.87

388

Other factor of the environment

1.73

0.93

1.1

1.60

7.64

u/ml

—

Focal epilepsy, strict definition

114

1332

0.85

0.93

1.1

5.80

5.85

u/ml

0.01

642

Complications following infusion, transfusion and therapeutic injection

1.73

0.93

1.0

0.64

7.21

u/ml

—

Pregnancy, childbirth and the puerperium

252

1465

0.90

0.93

1.1

6.75

7.45

u/ml

0.18

125

685

Other disorders of binocular movement

218

1.39

0.92

1.1

6.87

7.56

u/ml

0.08

Other congenital malformations of the digestive system

496

1.25

0.92

1.1

7.34

10.02

u/ml

0.51

282

Misadventures to patients during surgical and medical care

799

1.19

0.92

1.1

1.42

3.56

u/ml

2.69

351

Other mental disorders due to brain damage and dysfunction and to physical disease

326

0.70

0.91

1.0

1.1

1.02

3.17

u/ml

1.86

147

Other adrenocortical overactivity

1.73

0.90

1.0

1.1

2.87

14.37

u/ml

—

Constitutional tall stature

1.63

0.90

1.2

1.1

12.66

10.42

u/ml

—

Other arthritis (FG)

262

2368

1.11

0.90

1.0

1.1

2.56

5.03

u/ml

2.91

118

1043

Other diseases of arteries and capillaries

402

1.27

0.90

1.0

1.1

3.48

4.89

u/ml

0.32

178

Pre-eclampsia

176

1988

0.88

0.90

1.1

5.20

4.24

u/ml

0.22

875

Diseases of pulp and periapical tissues, including avohilmo

1047

5697

0.95

0.89

1.1

5.14

5.28

u/ml

0.08

497

2620

Benign neoplasm of major salivary glands

367

1.28

0.89

1.1

0.82

3.98

u/ml

3.03

161

Bitten or struck by other mammals

132

1145

1.16

0.89

1.1

5.58

5.35

u/ml

0.04

506

Superficial injury of ankle and foot

160

1407

1.14

0.89

1.1

7.49

6.38

u/ml

0.23

684

Hidradenitis suppurativa

381

0.73

0.88

1.1

8.02

4.92

u/ml

—

168

Ascites

230

0.65

0.88

1.0

1.1

1.93

2.25

u/ml

—

101

Torsion of testis

186

1.41

0.88

1.2

1.1

1.88

6.24

u/ml

1.90

Spermatocele

194

1.39

0.88

1.0

1.1

2.06

4.34

u/ml

0.89

Rheumatoid arthritis

165

1655

0.88

1.1

1.63

3.63

u/ml

2.35

670

Carcinoma in situ of skin of other and unspecified parts of face

1.65

0.88

1.0

1.1

1.58

1.82

u/ml

—

Burns and corrosions confined to eye and internal organs

186

1.41

0.87

1.1

1.16

4.62

u/ml

1.79

Acute peritonitis

253

0.67

0.87

1.1

0.86

4.74

u/ml

2.31

111

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

814

1.19

0.87

1.1

1.73

4.83

u/ml

2.73

353

Convalescence

316

1.30

0.87

1.2

1.1

1.45

4.53

u/ml

1.54

137

Other and unspecified injuries of ankle and foot

414

1.26

0.86

1.1

5.96

5.76

u/ml

0.03

188

Secondary and unspecified malignant neoplasm of lymph nodes

334

0.72

0.86

1.1

2.98

4.62

u/ml

0.37

145

Autoimmune thyroiditis

153

1.45

0.86

1.1

1.11

6.84

u/ml

—

Any mental disorder

1119

5334

1.05

0.86

1.1

6.27

4.67

u/ml

1.29

541

2368

Benign neoplasm: Cerebral meninges

343

1.29

0.86

1.1

4.10

2.64

u/ml

0.30

141

Contusion of ankle

388

1.27

0.85

1.1

6.97

6.29

u/ml

0.07

183

Presence of other functional implants

244

1849

0.90

0.85

1.1

5.63

3.69

u/ml

0.68

807

Intracerebral haemorrhage

310

0.71

0.85

1.0

1.1

3.90

2.47

u/ml

—

136

Inflammatory disease of cervix uteri

291

1.31

0.84

1.1

0.72

3.00

u/ml

1.80

121

Rheumatoid arthritis, including avohilmo

197

2201

0.89

0.84

1.1

2.11

3.84

u/ml

1.77

936

Foreign body in ear

137

1.47

0.84

1.1

6.68

10.08

u/ml

—

Maternal care for known or suspected abnormality of pelvic organs

376

2338

1.09

0.84

1.1

2.86

5.03

u/ml

2.38

169

1018

Diabetic maculopathy, excluding more controls

669

0.81

0.84

1.1

4.81

4.63

u/ml

0.02

301

Diseases of the digestive system

298

2702

1.10

0.83

1.1

5.81

5.21

u/ml

0.20

149

1243

Lesion of ulnar nerve

100

854

1.17

0.83

1.0

1.1

5.00

3.73

u/ml

0.17

368

Other orthopaedic follow-up care

292

1.31

0.83

1.1

3.36

4.64

u/ml

0.29

125

213

1.36

0.83

1.0

6.26

5.78

u/ml

0.03

Other congenital malformations of circulatory system

146

1.45

0.83

1.1

3.30

4.71

u/ml

0.24

Malignant melanoma of skin

422

0.76

0.82

1.1

0.71

2.76

u/ml

2.08

177

Glucosamine medication

145

1015

1.14

0.82

1.0

1.1

1.76

2.74

u/ml

0.78

418

Abscess of external ear

1.62

0.82

1.0

1.1

1.49

5.90

u/ml

—

Retention of urine

114

1065

0.86

0.82

1.1

3.03

3.18

u/ml

0.06

480

Septal defects

737

0.82

1.1

8.00

9.05

u/ml

0.17

410

Malignant melanoma of skin, including Hilmo

522

0.78

0.81

1.1

0.64

2.99

u/ml

3.27

207

Palmar fascial fibromatosis [Dupuytren]

364

1.27

0.81

1.0

1.1

4.27

3.03

u/ml

0.19

154

Necrosis of pulp, including avohilmo

560

5891

0.94

0.81

1.1

4.87

4.73

u/ml

0.07

252

2620

Puerperal sepsis

820

1.17

0.80

1.1

2.59

3.62

u/ml

0.46

334

Cardiovascular diseases

989

4994

1.05

0.80

1.1

5.00

6.10

u/ml

0.96

470

2377

Spina bifida

0.00

0.80

0.0

1.0

—

13.68

—

Other and unspecified injuries of forearm

1.75

0.80

1.1

1.91

9.26

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

276

1.31

0.80

1.1

5.37

3.52

u/ml

0.23

112

Other and unspecified epidermal thickening

147

1.44

0.80

1.1

6.14

6.42

u/ml

0.02

Psoriatic and enteropathic arthropathies

828

0.83

0.80

1.1

1.50

3.69

u/ml

1.66

354

Constipation

775

4967

1.06

0.80

1.1

2.95

5.25

u/ml

4.38

352

2282

Pediculosis and phthiriasis

0.00

0.80

0.0

1.1

—

5.23

—

Hypertrophy of bone

0.00

0.80

0.0

1.1

—

11.22

—

Pilonidal cyst

914

0.84

0.80

1.1

11.75

4.49

u/ml

0.43

405

Complications of anaesthesia during pregnancy

0.00

0.80

0.0

1.1

—

3.85

—

Syncope and collapse

329

2525

1.09

0.80

1.1

5.09

4.95

u/ml

0.05

150

1154

Biological medication for rheuma

162

1821

0.89

0.79

1.0

1.1

4.68

5.56

u/ml

0.27

829

Supernumerary ureter

0.00

0.79

0.0

1.1

—

9.98

—

Osteosarcoma, including Hilmo

0.00

0.79

0.0

1.1

—

7.01

—

Retinal detachment with retinal break

446

1.24

0.79

1.0

1.1

6.62

3.69

u/ml

0.34

199

Chronic myeloproliferative disease

0.00

0.79

0.0

1.1

—

0.65

—

Other disorders of bladder

419

1.24

0.79

1.1

6.17

3.32

u/ml

0.39

191

Hypogonadotropic hypogonadism

216

1.35

0.79

1.1

1.65

4.10

u/ml

1.02

110

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

0.00

0.79

0.0

1.1

—

10.95

—

Polycystic ovarian syndrome, consortium definition

846

4603

1.05

0.79

1.1

4.02

5.20

u/ml

1.21

365

2027

Carcinoma in situ of breast, intraductal

362

0.74

0.79

1.1

2.94

3.10

u/ml

0.03

143

Cysts of oral region, not elsewhere classified

348

1.27

0.79

1.0

1.1

2.69

5.37

u/ml

1.10

166

Acute gastritis

277

1.30

0.78

1.1

2.42

3.22

u/ml

0.16

117

Viral infections of the central nervous system

492

1.22

0.78

1.1

4.64

4.63

u/ml

0.00

221

Gout due to impairment of renal function

0.00

0.78

0.0

1.1

—

3.07

—

Myositis

1.54

0.78

1.0

1.1

0.61

6.79

u/ml

—

Primary open-angle glaucoma, strict

563

1.21

0.78

1.0

1.1

4.22

2.16

u/ml

0.31

246

Mixed and other personality disorders

738

0.82

0.78

1.1

7.11

3.85

u/ml

0.56

328

Other anaemias

166

1742

0.89

0.78

1.1

5.42

4.09

u/ml

0.45

793

Benign neoplasm: Sigmoid colon

620

1.20

0.78

1.0

1.1

1.70

3.02

u/ml

0.93

270

Malignant neoplasm of bladder

1.59

0.77

1.0

1.1

2.80

1.91

u/ml

—

Sequelae of injuries of lower limb

639

1.19

0.77

1.1

2.94

4.41

u/ml

0.67

279

Small cell lung cancer, helper endpoint

0.00

0.77

0.0

1.1

—

2.98

—

Other diseases of blood and blood-forming organs, wide

144

1272

1.13

0.77

1.1

2.07

4.42

u/ml

2.48

579

Other, unspecified and serous retinal detachments

115

1.48

0.77

1.0

1.1

16.10

2.00

u/ml

—

Toxic effects of substances chiefly nonmedicinal as to source

108

936

1.16

0.77

1.1

4.79

5.49

u/ml

0.19

439

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

376

1.25

0.77

1.0

1.1

5.40

3.85

u/ml

0.21

163

Retinal detachments and breaks

162

1442

1.12

0.77

1.1

3.97

3.39

u/ml

0.18

608

Adrenogenital disorders

0.00

0.77

0.0

1.0

—

11.70

—

Other benign neoplasms of skin

238

2164

1.10

0.76

1.1

5.58

4.11

u/ml

0.51

101

941

Bipolar affective disorders

217

1965

1.11

0.76

1.1

3.50

4.34

u/ml

0.52

111

876

Endovascular or surgical operations to intracerebral aneurysms

245

0.69

0.76

1.1

0.07

3.48

u/ml

—

102

Acquired absence of limb

0.00

0.76

0.0

1.0

—

5.70

—

Pulmonary heart disease, diseases of pulmonary circulation

147

1301

1.13

0.76

1.1

5.21

3.83

u/ml

0.27

566

Small cell lung cancer, including Hilmo

0.00

0.76

0.0

1.1

—

3.11

—

Small cell lung cancer

0.00

0.76

0.0

1.1

—

3.11

—

Persons encountering health services for specific procedures, not carried out

705

1.18

0.76

1.1

5.13

5.37

u/ml

0.04

314

Polyarthritis, unspecified

183

1.37

0.76

1.0

1.1

1.71

6.71

u/ml

2.17

Pyoderma

1.53

0.76

1.1

2.38

7.99

u/ml

—

Pedestrian injured in transport accident

449

1.23

0.76

1.1

2.90

4.73

u/ml

0.88

212

Used for control exclusion in common control thyroid runs

1111

5854

0.96

0.75

1.1

5.46

5.52

u/ml

0.03

504

2764

Malignant neoplasm of corpus uteri, including Hilmo

256

0.70

0.75

1.1

2.32

2.59

u/ml

—

109

CR(E)ST syndrome

1.65

0.75

1.1

1.0

1.09

2.77

u/ml

—

Other and unspecified immunodeficiencies with predominantly antibody defects

1.62

0.75

1.1

1.09

5.91

u/ml

—

Unspecified urinary incontinence

377

1.25

0.75

1.0

1.1

7.18

4.71

u/ml

0.29

171

Polymyalgia rheumatica

256

0.70

0.75

1.0

1.1

0.12

2.06

u/ml

—

113

Chromosomal abnormalities, not elsewhere classified

334

0.74

0.75

1.1

4.31

8.69

u/ml

1.17

198

Aortic aneurysm

601

1.19

0.75

1.1

1.71

2.69

u/ml

0.74

264

Psoriatic arthropathies, ICD10

647

0.82

0.75

1.1

0.98

3.74

u/ml

3.01

278

Complications following abortion and ectopic and molar pregnancy

141

1.42

0.74

1.1

0.39

2.83

u/ml

—

Dental caries, including avohilmo

626

3019

1.06

0.74

1.1

5.15

4.70

u/ml

0.21

301

1304

Episcleritis

378

1.25

0.74

1.1

6.81

3.98

u/ml

0.37

160

Pain, not elsewhere classified

257

2350

1.10

0.74

1.1

2.98

4.99

u/ml

1.81

110

1079

Intrahepatic Cholestasis of Pregnancy (ICP)

828

1.16

0.74

1.1

1.73

4.56

u/ml

2.31

341

Nontoxic multinodular goitre

827

1.16

0.74

1.1

1.92

3.34

u/ml

0.90

345

Macular hole

108

1.48

0.73

1.1

0.29

0.99

u/ml

—

Other and unspecified anaemias

165

1729

0.89

0.73

1.1

5.42

4.10

u/ml

0.44

788

Other congenital malformations of kidney

2.03

0.73

1.0

1.1

12.58

5.33

u/ml

—

Other disorders of the musculoskeletal system and connective tissue

726

1.17

0.73

1.0

1.1

3.50

3.69

u/ml

0.03

312

Other disorders of pigmentation

228

1.32

0.73

1.2

1.1

4.82

5.29

u/ml

0.04

Papilloedema, unspecified

159

1.39

0.73

1.1

18.89

8.92

u/ml

0.48

Campylobacter enteritis

159

1.39

0.72

1.0

1.1

8.48

4.53

u/ml

—

Other osteochondrodysplasias, including avohilmo

1.56

0.72

1.1

6.39

7.54

u/ml

—

Cramp and spasm

308

1.27

0.72

1.1

10.07

5.39

u/ml

0.43

144

Ovarian hyperstimulation (induction)

229

1.32

0.72

1.1

6.86

5.04

u/ml

0.24

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

858

1.16

0.72

1.1

1.69

4.65

u/ml

2.69

381

Background retinopathy and retinal vascular changes

1.56

0.72

1.0

1.1

1.22

3.68

u/ml

—

Fall on and from ladder

308

1.27

0.72

1.1

1.76

4.50

u/ml

1.25

139

Benign neoplasm: Pituitary gland, craniopharyngeal duct

335

1.26

0.72

1.0

1.1

2.18

5.06

u/ml

1.55

148

Arthropathies in other diseases classified elsewhere

168

1.37

0.71

1.1

1.48

4.80

u/ml

1.69

149

1328

1.12

0.71

1.1

6.02

5.16

u/ml

0.20

601

Osteoporosis

779

1.16

0.71

1.1

4.68

3.62

u/ml

0.24

344

Disorders of male genital organs in diseases classified elsewhere

1.94

0.71

1.2

1.0

—

2.23

—

Benign neoplasm of mouth and pharynx

526

1.20

0.71

1.1

4.05

3.65

u/ml

0.06

226

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

308

1.27

0.71

1.2

1.1

9.35

10.55

u/ml

0.12

196

Graves ophthalmopathy, strict

126

1.44

0.70

1.1

0.50

3.20

u/ml

1.52

Contact with nonpowered hand tool

256

1.29

0.70

1.1

2.08

3.59

u/ml

0.69

117

Benign neoplasm: Larynx

101

1.49

0.70

1.1

0.90

4.12

u/ml

—

Diseases of pulp and periapical tissues and dental caries

563

2718

1.06

0.70

1.1

5.56

4.84

u/ml

0.33

268

1168

Other and unspecified injuries of shoulder and upper arm

221

1.32

0.70

1.2

1.1

5.62

6.26

u/ml

0.06

101

Hydatidiform mole

118

1.45

0.70

1.0

3.76

6.02

u/ml

—

Malignant neoplasm of ovary

181

0.66

0.69

1.0

1.1

0.75

4.24

u/ml

—

Hypertrophic cardiomyopathy

169

0.65

0.69

1.0

1.1

18.43

7.05

u/ml

—

Ptosis of eyelid

391

1.23

0.69

1.1

2.61

3.37

u/ml

0.26

174

Glomerular disorders in diseases classified elsewhere

585

0.82

0.68

1.1

1.89

4.31

u/ml

1.79

261

Vestibular neuronitis

401

1.22

0.68

1.1

5.44

3.80

u/ml

0.26

176

Benign neoplasm: Long bones of lower limb

240

1.30

0.68

1.0

1.1

5.85

5.55

u/ml

—

111

Disorders resulting from impaired renal tubular function

168

0.65

0.67

1.1

0.36

5.78

u/ml

—

Tumor necrosis factor alpha inhibitors

148

1651

0.89

0.67

1.0

1.1

5.04

5.82

u/ml

0.21

745

Diseases caused by chlamydiae, including avohilmo

136

1.41

0.67

1.1

1.0

8.13

7.16

u/ml

—

Iron deficiency anaemia secondary to blood loss (chronic)

677

1.17

0.67

1.1

4.22

3.61

u/ml

0.11

300

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cat dander IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS